TSS:Rfhg 89494.1

Basic information about the TSS

---

TSS ID: rfhg_89494.1 TSS ID(Version3): hg_76422.1 Species: human Chr: chr6		Start: 158818183 End: 158818242 Strand: -
Source datasets	FANTOM5|EPD|DRA000914|ENCODE|RAMPAGE|PRJDB5282|PRJNA401781 |PRJNA4843412|PRJNA548673|PRJNA615891|DRA013844
Protocol	CAGE|TSS_database|RAMPAGE|C1CAGE|oligo_capping|NETCAGE |ReCappable-seq|SLIC_CAGE
TSS cluster detected*	14

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	PLS,CTCF-bound (EH38D3924584,EH38E2520211)
Category:	PLS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000337147.11:0 BC013903:0 FJ224318:0 X51521:0 BC068458:0 AK299456:0 GeneID: 7430 HGNC/MGI_ID: HGNC:12691 UniProt_ID: B7Z5V2 P15311 Q6NUR7 V9HW42 Nearer transcript ids and distances: J05021:16

Gene_name: ezrin Gene_symbol: EZR Gene_synonyms: Gene_source: HGNC:12691

TATA-Box annotation

---

Distance to TSS:	23
Nearest PromoterID:	NM_003379
Entrez ID:	7430
Nearest Unigene:	Hs.487027
Nearest Refseq:	NM_003379
Nearest Ensembl:	ENSG00000092820
Gene Name:	ezrin
Gene Alias:	CVIL|CVL|HEL-S-105|VIL2
Gene Type:	protein-coding
CpG%:	0.152542
GC%:	0.783333
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@EZR p2@EZR p3@EZR p4@EZR p5@EZR p6@EZR p7@EZR p8@EZR p9@EZR
Sample		p1@EZR	p2@EZR	p3@EZR	p4@EZR	p5@EZR	p6@EZR	p7@EZR	p8@EZR	p9@EZR
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	63.31	9.74	1.95	5.65	0.97	0.97	0.97	0.00	0.39
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	61.50	10.72	1.82	4.86	1.62	1.01	1.82	0.00	0.40
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	63.27	10.80	2.31	6.17	0.77	1.16	0.96	0.19	0.00
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	60.71	11.64	1.66	4.78	0.62	0.42	1.04	0.00	0.42
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	60.52	13.50	2.47	3.15	0.45	0.90	0.22	0.00	0.22
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	56.98	14.54	2.33	5.23	0.39	0.78	0.78	0.00	0.00
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	55.34	9.80	2.40	4.58	1.09	0.87	0.65	0.65	0.00
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	59.83	9.20	2.91	7.51	0.24	0.97	0.48	0.24	0.97
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	58.13	7.69	3.21	7.05	1.07	0.85	0.43	0.21	0.00
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	57.96	12.75	2.90	7.54	0.00	1.74	0.58	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	44.06	10.91	2.43	6.87	0.81	2.83	0.40	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	55.29	15.04	1.63	8.13	0.00	0.41	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	73.18	71.41	2.26	4.03	2.74	2.26	0.97	0.64	0.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	65.70	67.81	3.01	4.66	2.26	1.80	1.20	0.75	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	68.94	60.82	2.42	2.85	1.10	1.98	1.32	1.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	50.80	46.53	2.26	2.01	1.51	1.51	2.51	1.76	0.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	47.39	52.42	1.31	3.71	1.53	0.87	1.31	0.87	1.09
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	37.12	38.39	1.69	3.37	2.11	2.11	2.95	0.00	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	38.39	37.85	1.07	0.53	3.20	3.73	1.60	0.00	0.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	65.59	62.43	3.61	2.71	2.26	0.90	1.35	0.75	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	68.70	66.42	2.67	4.28	1.60	1.87	1.47	0.27	0.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	64.04	63.53	2.24	3.45	0.52	1.21	1.38	0.35	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	56.61	57.00	2.71	2.71	1.16	1.42	1.68	0.39	0.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	61.15	49.99	3.15	3.88	1.94	2.18	1.21	0.49	0.73
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	49.79	50.05	1.81	2.58	1.03	0.52	0.52	0.77	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	59.19	51.59	3.80	3.80	0.95	0.63	1.27	0.63	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	38.46	39.01	1.65	2.20	2.20	1.65	1.10	1.10	1.10
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	76.15	60.82	3.06	6.13	2.36	2.83	3.54	0.24	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	53.79	52.82	2.26	3.39	0.81	1.29	1.45	0.32	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	69.67	57.37	3.08	1.99	0.90	1.27	1.63	0.54	0.54
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	46.89	44.38	2.72	2.09	0.84	1.05	1.47	0.84	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	51.58	54.32	2.15	2.54	0.78	0.98	1.17	0.78	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	46.85	53.18	3.17	4.01	1.48	0.84	1.06	0.42	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	57.23	56.90	2.64	3.30	1.81	1.98	3.13	0.16	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	55.16	57.03	2.06	2.43	1.68	1.12	1.50	1.31	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	53.65	52.89	2.68	3.26	2.11	0.38	0.77	1.34	0.38
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	58.86	54.98	1.84	4.50	1.23	0.82	1.84	0.61	0.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	50.37	47.15	1.41	3.83	1.01	0.81	0.81	0.40	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	62.39	49.70	2.16	1.89	2.97	0.81	1.08	0.27	0.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	54.25	45.61	2.64	3.12	1.44	0.72	1.20	0.48	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	50.58	46.11	1.18	2.82	1.88	0.71	0.71	0.24	0.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	52.85	49.77	1.32	3.95	0.29	1.02	1.32	0.15	0.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	46.61	35.43	2.32	0.84	0.63	0.63	2.11	0.42	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	47.73	38.64	0.70	2.97	1.22	1.92	1.40	0.70	0.70
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	58.02	52.60	2.21	3.61	1.00	1.61	1.00	0.60	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	47.46	42.81	2.56	2.79	1.16	2.33	2.09	0.47	0.70
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	44.38	33.59	1.68	3.60	0.72	0.72	0.24	0.00	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	41.13	37.26	1.19	2.68	0.60	1.19	0.60	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	38.54	27.05	0.96	2.63	0.72	0.96	1.44	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	35.99	29.93	1.62	1.42	0.40	1.21	0.20	0.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	32.59	22.95	0.82	1.84	0.82	1.23	1.64	0.41	1.02
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	36.25	26.91	1.56	4.45	2.00	1.56	1.33	0.00	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	363.80	237.87	13.99	13.99	69.96	83.95	0.00	41.98	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	42.94	31.23	2.84	4.97	2.13	0.00	0.35	0.00	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	36.12	17.89	2.65	4.97	0.99	0.66	0.66	0.33	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	71.31	40.27	2.52	9.23	10.91	6.71	1.68	0.84	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	49.14	25.72	1.84	4.13	0.46	0.92	1.38	0.00	0.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	25.93	16.53	1.94	2.27	0.97	0.65	0.97	0.65	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	21.52	12.53	1.61	1.93	0.64	1.61	0.32	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	44.32	26.72	1.89	1.89	1.26	0.94	1.57	0.63	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	31.02	11.99	1.41	4.23	0.71	0.71	2.82	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	27.48	12.90	1.12	1.12	0.00	0.56	0.00	0.00	0.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	50.16	17.52	3.18	3.18	0.00	2.39	2.39	0.80	0.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	34.66	10.53	2.38	2.04	1.36	0.68	1.02	0.34	0.34
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	32.17	8.12	1.62	2.60	0.32	0.00	0.32	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	37.27	7.81	2.13	2.13	0.71	0.35	0.35	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	307.11	113.15	16.16	32.33	48.49	0.00	0.00	0.00	16.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	260.62	94.77	15.79	63.18	23.69	39.49	0.00	23.69	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	40.95	12.68	2.44	3.90	1.46	1.95	1.95	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	47.60	11.90	0.50	3.47	0.50	1.98	1.49	0.00	0.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	60.05	16.42	2.35	5.63	0.47	2.81	1.41	0.00	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	66.24	20.20	1.99	6.62	0.66	1.66	1.66	0.33	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	45.78	12.68	1.86	3.09	1.24	0.93	0.62	0.62	1.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	57.48	14.37	0.92	3.67	3.06	1.22	1.22	0.61	1.22
Adipocyte - breast, donor1	11376-118A8	3.64	1.27	0.48	0.16	0.32	0.32	0.00	0.00	0.00
Adipocyte - breast, donor2	11327-117E4	9.63	5.13	0.16	0.16	0.32	0.64	0.16	0.00	0.00
Adipocyte - omental, donor1	11473-119C6	6.49	4.07	0.64	0.38	0.51	0.00	0.00	0.13	0.00
Adipocyte - omental, donor2	11474-119C7	14.95	5.23	0.75	1.49	0.00	0.00	0.00	0.00	0.00
Adipocyte - omental, donor3	11475-119C8	3.01	0.33	0.33	0.67	0.00	0.33	0.00	0.00	0.00
Adipocyte - perirenal, donor1	11476-119C9	8.29	0.64	0.64	0.64	0.00	0.64	0.00	0.00	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	1.10	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	0.45	0.45	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	0.70	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Adipocyte differentiation, day04, donor1	13019-139D4	8.80	3.32	0.39	0.20	0.39	0.00	0.00	0.00	0.00
Adipocyte differentiation, day04, donor2	13022-139D7	2.83	0.77	0.51	0.51	0.00	0.00	0.00	0.00	0.00
Adipocyte differentiation, day04, donor3	13025-139E1	6.69	1.67	0.28	0.28	0.00	0.00	0.28	0.00	0.00
Adipocyte differentiation, day04, donor4	13028-139E4	4.11	1.18	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	13.51	2.01	1.37	1.05	0.00	0.08	0.00	0.00	0.00
Adipocyte differentiation, day08, donor2	13023-139D8	5.49	1.29	0.00	0.32	0.00	0.00	0.00	0.00	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	2.67	1.60	1.07	0.00	0.00	0.53	0.00	0.00	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	2.23	1.11	0.56	0.56	0.00	0.00	0.00	0.00	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	7.49	2.08	0.42	0.42	0.00	0.42	0.42	0.00	0.42
Adipocyte differentiation, day12, donor2	13024-139D9	8.04	3.01	0.25	0.75	0.00	0.00	0.25	0.00	0.00
Adipocyte differentiation, day12, donor3	13027-139E3	6.54	1.64	0.98	0.65	0.00	0.00	0.33	0.00	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	9.44	3.35	1.22	0.61	0.00	0.00	0.61	0.00	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	124.20	101.22	7.29	16.57	2.21	0.22	1.99	0.44	0.44
Alveolar Epithelial Cells, donor2	11590-120G6	95.38	64.90	5.74	7.53	2.51	2.51	0.36	0.00	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	20.37	27.55	1.20	1.20	0.00	2.40	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	183.68	224.16	7.02	20.15	4.14	3.96	3.24	0.18	1.08
Amniotic Epithelial Cells, donor2	11613-122A2	128.86	120.49	10.04	10.04	1.67	0.00	1.67	1.67	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	217.16	303.03	13.15	18.28	4.73	6.16	2.26	1.44	0.62
Anulus Pulposus Cell, donor1	11248-116E6	11.10	3.89	1.14	0.34	0.11	0.11	0.00	0.00	0.00
Anulus Pulposus Cell, donor2	11463-119B5	9.06	3.43	1.22	0.73	0.00	0.24	0.24	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	8.54	2.70	0.00	0.90	0.90	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	5.64	4.34	0.43	0.43	0.00	1.30	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	4.28	2.14	0.00	0.00	0.00	2.14	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	13.45	2.99	0.30	0.00	0.60	0.30	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	10.12	1.26	2.53	0.00	1.26	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	4.62	0.66	0.66	0.66	1.32	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	8.45	2.92	0.97	0.65	0.00	0.32	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	7.28	2.43	0.97	0.97	0.49	0.00	0.49	0.00	0.49
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	7.72	1.19	0.59	0.00	0.59	0.59	0.00	0.59	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	9.42	2.26	1.51	1.51	0.38	0.38	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	7.98	0.00	0.00	0.00	0.73	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	2.51	1.25	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	5.11	1.81	0.82	0.33	0.00	0.16	0.16	0.16	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	2.73	2.73	2.73	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	4.52	2.56	0.30	0.45	0.30	0.00	0.15	0.00	0.15
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	5.36	1.61	1.07	0.54	0.54	0.54	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	9.26	2.46	0.94	0.38	0.00	0.19	0.00	0.00	0.19
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	7.75	2.94	1.34	0.00	0.80	0.53	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	5.85	3.90	0.98	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	10.95	2.82	0.50	0.50	0.17	0.00	0.00	0.17	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	2.40	2.40	1.20	1.20	0.00	1.20	1.20	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	3.54	10.62	3.54	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	9.78	2.40	1.54	0.86	0.51	0.34	0.00	0.17	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	7.28	4.85	0.97	0.49	0.97	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	10.25	3.79	0.00	0.38	0.00	0.38	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	6.06	2.42	0.00	1.21	0.00	0.00	0.00	0.00	1.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	10.83	1.71	1.71	1.14	1.14	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	9.41	3.21	1.07	0.43	0.21	0.43	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	2.84	1.81	0.26	0.52	0.77	0.26	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	7.04	1.88	0.94	0.00	0.00	0.94	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	8.04	1.29	1.29	0.32	0.32	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	2.14	2.14	0.00	0.71	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	11.11	1.17	0.58	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	10.24	2.71	0.30	0.60	0.00	0.30	0.00	0.30	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	2.38	0.00	0.00	1.19	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	7.63	3.05	0.51	1.02	0.51	0.51	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	9.17	2.80	1.27	0.25	0.00	0.76	0.25	0.00	0.25
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	1.27	1.27	0.00	0.64	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	8.20	3.02	0.43	0.00	0.00	0.00	0.43	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	9.31	2.75	1.27	0.85	0.00	0.42	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	4.35	1.74	1.16	0.58	0.87	0.00	0.00	0.29	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	7.56	2.83	2.83	0.00	0.94	0.94	0.94	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	7.29	1.36	1.02	0.68	0.17	0.17	0.00	0.17	0.17
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	0.00	2.32	0.00	0.00	2.32	2.32	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	0.00	0.00	0.00	0.00	0.00	2.11	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	8.36	1.72	1.50	0.86	0.21	0.21	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	5.41	3.01	0.00	0.00	0.60	0.00	1.20	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	5.10	2.19	0.00	0.73	0.00	0.00	0.00	0.73	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	8.28	1.38	0.92	0.23	0.00	0.23	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	7.65	2.55	2.55	2.55	5.10	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	2.29	2.03	1.02	0.51	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	7.02	3.10	1.03	0.21	0.62	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	7.65	1.22	0.31	0.31	0.31	0.31	0.31	0.00	0.31
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	9.08	2.39	1.43	0.48	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	8.20	2.66	0.00	0.00	0.22	0.22	0.00	0.00	0.22
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	1.53	3.05	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	3.88	2.22	0.55	0.00	0.55	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	6.36	2.65	0.53	0.79	0.79	0.00	0.79	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	3.27	2.54	0.00	0.36	0.00	0.36	0.00	0.00	0.00
Astrocyte - cerebellum, donor1	11500-119F6	47.16	10.44	6.51	3.81	1.35	0.49	0.37	0.12	0.00
Astrocyte - cerebellum, donor2	11580-120F5	44.67	14.04	3.94	1.54	0.86	0.34	0.51	0.17	0.00
Astrocyte - cerebellum, donor3	11661-122F5	22.02	11.75	1.89	0.84	0.42	0.00	0.21	0.00	0.21
Astrocyte - cerebral cortex, donor1	11235-116D2	153.03	97.95	11.15	6.97	1.74	1.74	0.00	0.00	0.35
Astrocyte - cerebral cortex, donor2	11316-117D2	171.97	109.04	12.13	9.38	8.57	4.85	1.62	1.94	1.46
Astrocyte - cerebral cortex, donor3	11392-118C6	206.14	123.21	13.72	11.04	4.62	3.73	1.79	1.19	1.19
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	169.73	34.64	17.32	4.13	4.01	2.41	1.15	1.38	0.80
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	184.67	40.72	18.67	8.02	2.63	2.88	1.25	0.50	0.63
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	162.27	36.87	17.18	5.01	3.19	1.82	0.80	0.68	1.02
Basophils, donor1	12241-129G9	75.32	64.34	7.32	9.15	0.52	0.26	1.31	0.00	0.26
Basophils, donor2	12242-129H1	89.48	102.83	4.69	14.43	1.44	0.00	0.00	0.36	0.00
Basophils, donor3	12243-129H2	114.36	64.24	6.61	7.94	0.29	0.59	0.00	0.15	0.15
Bronchial Epithelial Cell, donor1	11511-119G8	64.90	48.30	3.02	5.39	1.51	1.51	0.86	0.00	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	22.86	9.60	3.20	0.91	0.46	0.00	1.37	0.00	0.91
Bronchial Epithelial Cell, donor3	11672-122G7	35.87	14.35	0.00	7.17	0.00	0.00	7.17	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	53.98	32.01	5.02	5.65	1.88	0.00	1.88	0.00	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	93.99	35.56	3.95	3.54	1.25	0.21	0.21	0.00	0.42
Bronchial Epithelial Cell, donor6	11461-119B3	46.52	26.94	1.38	3.68	0.92	1.38	1.15	0.23	0.00
Bronchial Epithelial Cell, donor7	11769-123I5	61.18	40.13	4.32	3.42	4.14	3.06	0.36	1.08	0.90
Burkitt's lymphoma cell line:DAUDI	10422-106C8	250.94	68.63	18.86	18.55	3.09	2.47	1.34	1.13	0.82
Burkitt's lymphoma cell line:RAJI	10476-106I8	236.16	81.75	17.47	14.44	5.12	3.49	2.10	0.93	0.93
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	44.13	4.16	8.63	2.56	0.32	0.32	0.00	0.32	0.00
CD133+ stem cells - cord blood derived, pool1	12223-129E9	62.05	0.00	10.34	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	63.12	41.70	8.45	16.91	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor2	11305-117B9	75.91	56.79	5.20	13.18	2.23	2.60	0.56	0.74	0.37
CD14+ Monocytes, donor3	11381-118B4	82.11	46.32	6.37	21.73	1.76	1.32	0.44	0.00	0.66
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	24.06	21.79	2.55	0.85	0.28	0.28	0.57	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	37.15	33.74	2.65	0.76	1.14	0.76	0.76	0.00	0.38
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	27.94	24.00	2.63	0.66	0.33	0.00	0.33	0.00	0.00
CD14+ monocytes - mock treated, donor1	11863-125A9	103.64	53.77	5.20	4.77	3.04	1.16	2.17	2.17	0.87
CD14+ monocytes - mock treated, donor2	11873-125C1	70.31	38.32	3.92	4.53	0.60	0.60	0.30	0.60	0.30
CD14+ monocytes - mock treated, donor3	11883-125D2	80.07	46.19	3.08	4.26	1.66	0.47	0.95	0.95	0.47
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	61.44	43.19	3.18	3.85	1.67	1.34	2.34	0.84	0.33
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	50.51	38.92	2.76	1.93	0.83	0.55	1.38	0.00	0.28
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	57.77	65.95	4.21	4.71	2.23	1.24	1.74	0.99	0.25
CD14+ monocytes - treated with BCG, donor1	11860-125A6	38.57	30.35	1.76	2.94	1.76	0.39	0.78	0.39	0.59
CD14+ monocytes - treated with BCG, donor2	11870-125B7	31.51	24.04	3.20	1.07	0.53	0.89	0.53	0.53	0.00
CD14+ monocytes - treated with BCG, donor3	11880-125C8	34.60	42.66	3.48	3.48	1.31	0.65	1.31	0.22	0.44
CD14+ monocytes - treated with Candida, donor1	11868-125B5	74.92	125.26	4.92	5.62	2.34	1.40	1.40	0.70	0.94
CD14+ monocytes - treated with Candida, donor2	11878-125C6	67.06	83.96	6.86	8.98	0.53	1.58	0.53	0.53	1.06
CD14+ monocytes - treated with Candida, donor3	11888-125D7	58.80	117.59	3.33	1.11	4.44	0.00	1.11	1.11	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	82.11	69.47	5.06	5.65	4.61	2.08	1.64	1.49	0.59
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	56.87	42.10	3.39	4.79	2.59	0.80	1.40	0.40	0.20
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	61.21	52.88	3.12	5.41	0.83	2.08	0.83	0.21	0.42
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	123.77	142.30	5.72	8.47	6.41	4.58	2.97	2.75	2.06
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	60.17	61.53	4.98	5.66	1.58	0.90	0.45	0.23	0.45
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	84.24	129.19	4.36	7.86	3.06	0.44	2.62	0.87	0.44
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	40.08	25.29	3.50	1.61	0.81	0.81	0.00	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	49.20	24.60	3.14	2.27	1.22	0.70	1.57	0.52	0.52
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	36.19	33.24	3.79	1.68	1.68	0.84	0.84	1.26	0.42
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	69.44	53.64	3.86	4.23	5.51	2.02	1.65	1.29	0.73
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	39.10	32.76	2.11	2.82	0.35	1.06	0.35	0.35	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	48.70	50.45	2.63	3.07	0.44	1.32	1.32	0.00	0.88
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	40.63	40.80	1.92	0.87	1.39	1.22	0.17	0.35	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	40.88	35.68	5.20	1.12	4.09	1.86	1.12	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	44.40	57.12	2.59	1.94	0.22	0.65	0.65	0.43	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	57.74	59.79	1.23	3.28	3.69	2.05	1.64	1.23	2.05
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	41.26	45.43	3.71	4.40	0.00	0.00	0.93	0.23	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	35.73	47.79	4.18	2.55	0.46	0.23	0.23	0.23	0.46
CD14+CD16+ Monocytes, donor1	11789-124B7	54.49	20.71	5.89	7.41	0.87	0.00	0.44	0.44	0.22
CD14+CD16+ Monocytes, donor2	11801-124D1	50.82	33.26	4.39	5.08	1.39	0.69	0.69	0.46	0.69
CD14+CD16+ Monocytes, donor3	11912-125G4	47.01	16.68	4.55	5.42	0.22	0.00	0.00	0.00	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	52.01	12.77	3.89	5.14	0.62	0.31	0.00	0.47	0.00
CD14+CD16- Monocytes, donor2	11799-124C8	44.19	12.92	4.89	5.24	0.52	0.52	0.52	0.35	0.00
CD14+CD16- Monocytes, donor3	11910-125G2	56.19	11.59	5.35	6.69	0.22	0.67	0.67	0.00	0.00
CD14-CD16+ Monocytes, donor1	11790-124B8	37.77	23.48	3.32	4.59	0.51	0.26	0.77	0.00	0.26
CD14-CD16+ Monocytes, donor2	11800-124C9	50.94	23.05	3.29	3.51	1.54	0.44	0.22	0.22	0.44
CD14-CD16+ Monocytes, donor3	11911-125G3	50.11	25.90	2.74	4.84	0.21	0.21	0.63	0.21	0.42
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	203.23	77.23	20.32	18.29	0.00	0.00	0.00	2.03	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	227.12	96.27	14.92	15.59	0.00	2.03	1.36	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	208.16	97.35	12.43	16.57	2.07	0.00	0.00	0.00	1.04
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	212.15	46.91	11.19	8.53	0.53	1.07	1.07	0.53	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	261.60	101.32	15.55	20.91	1.07	2.68	0.00	1.61	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	247.08	103.89	11.23	21.76	0.70	0.70	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	208.64	85.49	11.77	14.12	1.57	0.78	0.78	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	234.65	122.60	22.41	23.73	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	591.77	297.53	20.55	96.16	5.75	8.22	4.93	1.64	2.47
CD19+ B Cells, donor2	11624-122B4	649.98	362.71	26.12	119.70	11.61	12.33	6.53	4.35	4.35
CD19+ B Cells, donor3	11705-123B4	699.18	404.37	19.18	117.12	18.68	9.09	3.53	2.02	4.04
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	51.72	7.68	5.25	0.81	0.00	0.40	0.00	0.40	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	34.76	2.80	2.00	0.80	0.00	0.00	0.00	0.00	0.40
CD34+ Progenitors, donor1	11545-120B6	29.12	23.09	0.00	4.02	1.00	0.00	0.00	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	120.23	95.51	9.55	10.67	0.00	0.00	1.12	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	54.86	4.88	11.27	1.88	0.00	0.00	0.00	0.00	0.38
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	40.14	3.83	6.31	1.80	0.00	0.00	0.00	0.00	0.00
CD4+ T Cells, donor1	11225-116C1	178.89	188.53	12.85	38.21	1.07	1.43	1.07	1.07	0.71
CD4+ T Cells, donor2	11306-117C1	184.32	207.59	14.70	49.60	6.74	7.35	3.67	0.61	1.84
CD4+ T Cells, donor3	11382-118B5	222.04	383.07	13.72	60.39	9.45	3.35	4.27	2.44	2.74
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	70.45	40.33	6.89	3.06	1.53	0.51	0.51	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	59.29	36.38	5.39	4.04	1.35	0.90	0.90	0.22	0.22
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	43.69	33.35	5.46	1.72	0.57	0.00	0.00	0.29	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	131.32	105.25	4.74	24.65	1.90	0.00	0.47	0.95	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	117.29	120.10	7.73	25.99	0.70	0.70	1.40	0.70	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	69.22	62.63	3.30	39.55	0.00	0.00	3.30	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	76.74	52.60	6.21	6.21	0.87	1.30	1.01	0.87	0.14
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	65.75	48.47	7.80	4.07	2.20	1.36	0.34	1.53	1.02
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	58.84	39.01	5.48	4.67	3.22	2.10	0.97	0.97	0.32
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	147.04	204.87	8.52	30.93	0.90	1.34	3.14	1.34	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	147.79	173.65	7.69	19.22	2.10	1.75	2.80	0.35	0.70
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	158.83	179.51	11.00	27.72	2.64	1.76	1.32	0.44	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	50.18	30.78	6.32	3.79	0.84	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	51.32	27.63	5.40	1.87	2.91	1.66	0.83	0.83	0.42
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	37.76	22.05	3.34	3.34	0.67	1.34	1.00	0.67	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	103.61	48.95	11.15	19.31	0.54	0.27	0.54	0.54	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	90.04	34.30	6.43	17.15	0.54	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	84.28	32.28	5.38	21.52	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	95.87	71.39	9.27	5.01	0.93	0.56	0.37	0.74	0.37
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	90.55	54.59	4.98	6.50	0.65	0.22	1.08	0.00	0.22
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	83.85	48.97	5.46	4.20	1.47	0.42	0.21	0.63	0.42
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	129.94	119.83	6.57	36.91	0.51	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	132.14	135.17	10.40	38.56	0.87	0.00	0.43	0.00	0.43
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	148.61	107.21	11.77	28.76	2.61	0.87	1.31	0.87	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	107.39	61.36	9.90	4.95	0.00	0.49	0.00	0.49	1.48
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	99.70	56.31	10.16	6.46	2.77	0.00	0.92	0.92	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	107.48	44.67	8.37	2.79	0.00	0.00	1.40	1.40	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	140.96	67.02	12.46	5.54	1.38	0.00	1.11	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	156.80	73.13	14.48	6.38	0.98	0.49	0.49	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	84.70	67.76	4.62	3.08	0.00	1.54	1.54	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	132.15	73.41	14.32	2.51	0.72	0.36	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	121.88	91.41	12.46	2.77	1.38	1.38	1.38	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	186.94	195.13	10.80	40.27	2.62	3.27	0.65	0.98	0.00
CD8+ T Cells, donor2	11307-117C2	210.62	232.39	8.26	43.93	11.26	8.26	5.63	1.50	1.50
CD8+ T Cells, donor3	11383-118B6	216.64	165.13	6.82	48.73	4.80	4.80	2.27	2.52	0.50
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	51.38	12.39	6.42	5.96	1.84	0.23	0.46	0.00	0.00
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	48.17	9.59	6.71	4.79	1.44	1.68	0.48	0.48	1.20
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	39.40	8.48	5.47	5.75	2.19	1.92	0.82	0.00	0.27
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	68.45	15.61	4.20	12.01	0.90	1.20	0.00	0.30	0.00
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	48.72	10.80	4.08	5.52	0.48	0.72	0.72	0.00	0.48
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	48.21	12.73	4.32	5.46	0.00	0.45	0.68	0.23	0.00
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	65.19	9.78	6.08	8.47	0.87	1.74	0.65	0.00	0.22
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	56.59	6.05	4.74	4.21	1.05	0.79	1.05	0.00	0.00
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	59.80	8.21	5.39	7.27	0.70	1.17	0.47	0.23	0.00
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	70.34	9.06	6.64	11.77	1.21	1.81	1.51	0.30	0.00
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	48.22	5.52	4.65	7.26	0.87	0.58	0.87	0.29	0.29
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	83.13	11.19	6.93	6.93	0.27	0.27	1.33	0.27	0.00
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	71.35	53.84	4.38	16.20	0.44	0.00	0.44	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	66.04	55.11	5.47	14.12	0.00	0.46	0.00	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	46.99	38.04	2.98	9.70	0.75	0.00	0.75	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	48.62	20.17	5.40	9.36	1.08	0.36	0.72	0.00	0.36
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	52.94	18.13	5.75	7.77	0.29	0.58	0.58	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	41.25	16.26	4.95	4.01	0.94	1.18	0.94	0.71	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	73.52	13.63	6.02	13.31	0.95	1.27	0.63	0.00	0.32
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	66.13	8.30	6.46	9.53	0.62	1.85	0.92	0.00	0.31
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	56.10	12.18	6.41	7.37	0.96	0.00	0.00	0.00	0.32
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	60.81	8.80	7.65	8.03	0.76	0.38	0.76	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	57.93	4.73	8.28	7.49	1.58	0.79	1.18	0.39	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	37.06	6.05	6.81	6.81	1.51	1.51	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	52.19	45.77	5.62	17.67	0.80	0.80	1.61	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	52.46	46.86	3.50	9.09	1.40	0.00	1.40	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	81.14	37.06	5.01	9.02	0.00	0.00	0.00	0.00	0.00
Cardiac Myocyte, donor1	11525-119I4	10.97	9.14	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	14.33	1.48	0.99	0.99	0.00	0.99	0.00	0.00	0.00
Cardiac Myocyte, donor3	11686-122I3	46.83	8.10	3.58	2.00	0.21	0.53	0.00	0.11	0.00
Chondrocyte - de diff, donor1	11261-116G1	49.23	21.84	4.16	4.85	0.69	0.35	0.00	0.00	0.00
Chondrocyte - de diff, donor2	11338-117F6	10.31	4.62	1.78	0.36	0.00	0.00	0.36	0.00	0.00
Chondrocyte - de diff, donor3	11410-118E6	19.57	11.38	1.25	0.57	0.34	0.34	0.00	0.23	0.00
Chondrocyte - re diff, donor2	11339-117F7	18.80	3.58	2.69	1.79	0.00	0.00	0.00	0.90	0.00
Chondrocyte - re diff, donor3	11411-118E7	11.73	3.64	1.62	0.40	0.40	0.00	0.00	0.00	0.40
Ciliary Epithelial Cells, donor1	11242-116D9	51.30	22.26	5.97	1.95	0.46	0.80	0.34	0.11	0.23
Ciliary Epithelial Cells, donor2	11323-117D9	44.04	26.72	4.06	2.14	1.71	1.50	0.86	0.00	0.00
Ciliary Epithelial Cells, donor3	11399-118D4	53.01	27.08	3.01	3.36	0.88	0.88	0.35	0.53	0.09
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	66.76	86.93	7.43	4.95	2.29	1.47	1.10	0.83	0.46
Corneal Epithelial Cells, donor1	11526-119I5	65.43	33.81	4.61	3.29	0.66	0.00	0.66	0.66	0.00
Corneal Epithelial Cells, donor2	11606-120I4	45.50	48.92	7.96	1.14	3.41	2.28	0.00	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	89.47	58.28	4.86	6.65	1.02	2.05	1.02	0.51	0.26
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	21.46	10.57	2.81	0.99	0.83	0.17	0.33	0.33	0.17
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	28.39	10.09	3.15	1.58	0.00	0.32	0.32	0.32	0.32
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	34.51	10.35	3.45	0.00	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	26.03	8.75	1.94	0.97	0.65	0.65	0.22	0.43	0.11
Dendritic Cells - plasmacytoid, donor1	11228-116C4	147.25	47.15	9.22	10.93	0.00	0.00	0.68	0.34	0.34
Dendritic Cells - plasmacytoid, donor2	11309-117C4	135.14	62.68	5.22	9.79	0.65	0.00	0.00	0.65	0.65
Dendritic Cells - plasmacytoid, donor3	11385-118B8	182.45	55.17	8.71	8.23	1.45	0.00	0.48	0.00	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	47.03	9.01	4.00	0.50	0.17	0.00	0.17	0.17	0.00
Endothelial Cells - Aortic, donor1	11263-116G3	28.75	3.52	1.76	0.59	0.00	0.59	0.59	0.00	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	25.73	13.01	1.70	1.98	0.28	0.57	0.57	0.00	0.28
Endothelial Cells - Aortic, donor3	11412-118E8	19.27	10.22	2.36	0.39	0.39	0.39	0.39	0.39	0.00
Endothelial Cells - Artery, donor1	11264-116G4	32.00	8.73	1.75	2.04	0.29	0.29	0.00	0.00	0.00
Endothelial Cells - Artery, donor2	11341-117F9	31.53	8.47	2.82	0.71	1.65	1.18	0.71	0.00	0.00
Endothelial Cells - Artery, donor3	11413-118E9	48.39	11.22	3.16	2.28	0.35	0.35	0.35	0.00	0.35
Endothelial Cells - Lymphatic, donor1	11236-116D3	26.38	18.40	2.44	0.89	0.22	0.22	0.00	0.22	0.22
Endothelial Cells - Lymphatic, donor2	11317-117D3	22.52	25.25	1.52	1.22	0.30	0.00	0.00	0.00	0.00
Endothelial Cells - Lymphatic, donor3	11393-118C7	20.86	20.86	2.82	1.13	0.28	0.00	0.56	0.00	0.00
Endothelial Cells - Microvascular, donor1	11265-116G5	30.60	10.10	2.97	2.08	0.30	0.30	0.59	0.00	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	18.22	4.69	2.08	1.04	0.52	0.00	0.52	0.00	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	35.16	11.91	2.98	1.28	0.28	0.85	0.28	0.14	0.28
Endothelial Cells - Thoracic, donor1	11266-116G6	47.21	7.60	2.80	0.80	0.00	0.40	0.00	0.00	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	15.72	2.62	0.00	0.00	1.57	0.00	0.00	0.00	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	61.63	9.32	8.08	1.74	0.62	0.50	0.37	0.12	0.00
Endothelial Cells - Umbilical vein, donor2	11324-117E1	46.06	7.17	4.56	0.87	0.22	1.09	0.00	0.00	0.22
Endothelial Cells - Umbilical vein, donor3	11400-118D5	69.73	7.82	7.69	0.85	0.49	0.73	0.24	0.12	0.24
Endothelial Cells - Vein, donor1	11267-116G7	30.71	3.41	5.69	2.28	0.00	1.14	0.00	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	22.35	7.68	2.10	0.00	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	33.44	7.22	3.61	0.47	0.16	0.63	0.16	0.31	0.00
Eosinophils, donor1	12244-129H3	45.74	60.99	15.25	0.00	0.00	0.00	15.25	0.00	0.00
Eosinophils, donor2	12245-129H4	56.11	29.70	9.90	6.60	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor3	12246-129H5	35.67	17.83	7.13	0.00	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	47.40	31.03	4.40	3.91	0.73	0.49	1.22	0.24	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	31.20	31.20	2.08	6.24	0.00	2.08	0.00	0.00	2.08
Esophageal Epithelial Cells, donor3	11668-122G3	81.34	16.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	13.55	7.39	2.46	0.00	0.82	0.00	0.41	0.00	0.00
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	3.39	1.97	0.55	0.77	0.44	0.11	0.22	0.11	0.00
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	13.33	2.49	0.98	1.08	0.22	0.43	0.22	0.00	0.00
Fibroblast - Aortic Adventitial, donor1	11245-116E3	31.05	8.49	4.00	0.97	0.49	0.97	0.36	0.24	0.00
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	21.84	10.51	1.36	0.82	0.00	0.14	0.00	0.14	0.00
Fibroblast - Aortic Adventitial, donor2	11326-117E3	16.14	8.96	1.48	0.74	0.53	0.32	0.11	0.11	0.11
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	35.31	4.48	3.16	2.37	0.53	0.26	0.26	0.00	0.00
Fibroblast - Aortic Adventitial, donor3	11401-118D6	56.81	19.27	3.65	1.66	1.00	0.33	1.33	0.33	1.00
Fibroblast - Cardiac, donor1	11268-116G8	41.73	18.60	1.81	3.18	0.91	0.45	0.00	0.00	0.45
Fibroblast - Cardiac, donor2	11345-117G4	16.67	3.79	3.03	1.52	0.00	0.00	0.00	0.00	0.00
Fibroblast - Cardiac, donor3	11417-118F4	18.61	11.99	0.79	2.05	1.89	0.32	0.00	0.00	0.00
Fibroblast - Cardiac, donor4	11452-119A3	18.19	6.37	1.82	0.91	0.00	0.00	0.00	0.00	0.00
Fibroblast - Cardiac, donor5	11456-119A7	45.05	10.03	3.81	1.14	0.63	0.51	0.38	0.25	0.13
Fibroblast - Cardiac, donor6	11460-119B2	36.23	7.28	2.73	0.91	1.21	0.30	0.30	0.30	0.15
Fibroblast - Choroid Plexus, donor1	11492-119E7	19.29	13.13	1.61	1.07	0.00	0.13	0.00	0.00	0.00
Fibroblast - Choroid Plexus, donor2	11572-120E6	10.35	4.75	0.00	0.43	0.00	1.29	0.00	0.00	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	42.48	7.32	4.39	1.46	5.86	1.46	0.00	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	62.73	9.46	6.46	3.92	0.69	0.23	0.23	0.46	0.23
Fibroblast - Conjunctival, donor3	11692-122I9	6.78	2.20	0.68	0.17	0.00	0.00	0.00	0.17	0.00
Fibroblast - Dermal, donor1	11269-116G9	5.40	0.23	0.70	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Dermal, donor2	11346-117G5	34.90	4.25	2.36	1.89	0.47	0.00	0.00	0.00	0.00
Fibroblast - Dermal, donor3	11418-118F5	8.58	1.21	1.69	0.00	0.12	0.12	0.00	0.00	0.12
Fibroblast - Dermal, donor4	11450-119A1	51.77	2.37	4.63	1.13	0.45	0.34	0.23	0.23	0.34
Fibroblast - Dermal, donor5	11454-119A5	39.95	2.09	4.71	1.05	0.87	0.17	0.17	0.00	0.00
Fibroblast - Dermal, donor6	11458-119A9	52.14	1.95	4.71	1.46	0.65	0.16	0.00	0.16	0.00
Fibroblast - Gingival, donor1	11237-116D4	20.20	2.29	2.29	0.42	0.21	0.00	0.00	0.00	0.00
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	36.68	14.41	3.41	1.83	0.79	1.31	0.26	0.26	0.00
Fibroblast - Gingival, donor2	11318-117D4	51.66	4.74	5.40	1.05	1.19	0.92	0.79	0.40	0.13
Fibroblast - Gingival, donor3	11394-118C8	18.27	4.64	1.84	0.58	0.10	0.10	0.10	0.39	0.00
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	17.66	2.08	1.04	0.00	1.04	0.00	0.00	0.00	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	17.62	5.99	1.59	0.00	0.70	0.53	0.18	0.18	0.18
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	40.84	2.65	3.74	1.25	0.47	0.00	0.00	0.31	0.16
Fibroblast - Gingival, donor6 (control)	11922-125H5	47.87	8.52	3.65	1.35	0.68	0.41	0.95	0.14	0.14
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	34.58	6.70	3.53	1.41	0.00	0.00	0.35	0.00	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	34.51	13.60	4.09	1.90	0.44	1.90	0.15	0.29	0.00
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	40.09	5.18	3.95	2.32	0.55	0.55	0.41	0.14	0.27
Fibroblast - Gingival, donor8 (control)	11926-125H9	58.36	10.20	7.13	2.96	0.77	0.99	0.00	0.11	0.22
Fibroblast - Gingival, donor9 (control)	11927-125I1	12.03	7.34	1.47	0.15	0.15	0.00	0.00	0.00	0.00
Fibroblast - Lung, donor1	11270-116H1	31.27	2.72	4.08	1.36	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	35.81	10.45	8.95	1.49	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	37.14	9.29	1.69	0.84	0.63	0.42	0.84	0.21	0.00
Fibroblast - Lymphatic, donor1	11506-119G3	66.64	25.82	5.83	5.83	0.00	0.00	0.00	0.83	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	37.76	9.79	0.00	1.40	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	12.31	6.72	0.28	1.40	0.28	0.28	0.00	0.00	0.00
Fibroblast - Mammary, donor1	11540-120B1	77.13	12.59	5.28	2.84	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor2	11620-122A9	27.96	3.99	3.99	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	17.87	11.91	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	49.66	7.56	6.98	0.78	0.39	0.19	0.39	0.19	0.00
Fibroblast - Periodontal Ligament, donor2	11319-117D5	76.60	4.70	8.80	1.06	1.52	1.67	0.30	0.15	0.46
Fibroblast - Periodontal Ligament, donor3	11395-118C9	55.08	8.26	3.67	1.22	0.61	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	37.40	12.21	4.20	2.29	0.76	0.00	0.38	0.38	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	26.46	11.34	2.70	0.54	1.35	0.27	0.27	0.00	0.27
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	16.12	9.51	1.16	1.04	0.35	0.35	0.23	0.12	0.00
Fibroblast - Pulmonary Artery, donor1	11250-116E8	41.01	10.83	2.98	2.21	0.55	0.55	0.22	0.00	0.11
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	69.69	16.46	4.27	3.86	0.41	0.20	0.41	0.00	0.20
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	29.40	4.01	2.67	0.67	0.00	0.00	0.67	0.67	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	13.05	0.00	1.58	0.79	0.40	0.00	0.79	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	177.61	57.55	14.69	7.74	2.58	1.19	1.59	0.20	0.79
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	15.45	9.06	1.07	1.07	0.53	0.18	0.00	0.36	0.00
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	14.39	3.94	2.37	0.59	0.39	0.00	0.20	0.00	0.20
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	148.02	49.64	6.92	9.93	0.60	0.90	1.20	0.30	0.30
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	54.84	14.57	3.89	2.91	0.43	0.43	0.32	0.00	0.11
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	96.67	34.42	5.82	5.06	1.01	0.51	0.76	0.00	0.25
Fibroblast - skin normal, donor1	11553-120C5	24.94	12.96	2.63	1.15	0.33	0.00	0.00	0.16	0.00
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	76.19	21.25	6.82	4.81	1.00	0.40	0.20	0.20	0.20
Fibroblast - skin normal, donor2	11561-120D4	42.29	11.35	4.22	2.31	0.70	0.20	0.10	0.00	0.00
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	124.82	35.66	6.95	6.04	0.60	2.12	0.60	0.00	0.00
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	15.49	6.21	1.49	0.66	0.08	0.17	0.00	0.08	0.00
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	24.27	10.43	1.88	0.51	0.85	0.00	0.00	0.00	0.17
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	82.11	25.95	5.25	3.94	0.00	1.31	0.99	0.00	0.33
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	84.26	29.40	6.71	5.86	1.17	0.32	0.21	0.11	0.43
Fibroblast - skin walker warburg, donor1	11554-120C6	77.59	23.78	6.24	3.88	2.36	0.84	0.84	0.51	0.17
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	28.38	12.86	1.73	1.88	1.25	0.78	0.94	0.31	0.47
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	288.08	132.96	0.00	44.32	0.00	0.00	0.00	0.00	22.16
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	81.05	47.06	3.49	2.61	4.36	2.61	0.00	0.00	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	63.28	68.30	3.81	5.37	1.39	1.21	0.35	0.35	0.17
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	89.26	51.27	4.42	4.68	1.82	0.26	1.04	0.00	0.26
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	82.28	72.31	3.32	5.11	1.02	0.00	1.02	0.51	0.26
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	83.45	22.20	4.59	7.66	0.77	1.53	0.77	0.77	0.77
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	90.61	16.59	8.29	7.66	3.83	1.91	0.64	1.28	0.64
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	131.22	28.53	12.27	7.70	3.42	2.85	0.86	0.57	1.43
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	32.26	2.76	4.96	0.83	0.28	1.65	0.00	0.55	0.55
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	32.65	13.93	4.34	1.14	1.37	1.60	0.23	0.68	0.23
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	99.46	20.21	8.32	5.35	2.38	1.39	0.40	0.59	0.20
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	30.13	5.29	5.02	0.53	0.26	0.26	0.26	0.26	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	43.70	24.79	5.22	2.61	0.98	1.63	0.65	0.33	0.33
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	109.23	32.28	14.15	5.31	4.86	7.08	0.44	1.77	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	160.82	39.85	14.56	10.18	2.40	1.41	1.27	0.71	0.28
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	107.38	45.19	11.94	6.28	3.20	2.59	0.99	0.74	0.25
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	126.52	41.91	9.67	10.21	2.15	3.49	1.61	1.61	0.54
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	118.07	69.75	8.05	7.93	2.23	1.73	1.36	0.87	0.87
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	158.64	100.08	16.06	7.89	2.77	5.40	0.83	1.11	1.11
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	136.21	58.96	11.99	7.32	6.71	3.46	3.86	2.03	1.02
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	65.26	44.49	4.79	4.79	2.05	0.68	0.68	0.91	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	122.70	102.77	9.34	6.35	2.99	3.11	0.37	1.49	0.87
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	129.40	78.47	7.87	8.52	3.28	2.40	1.09	0.44	1.31
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	38.41	23.34	4.14	1.48	0.00	0.30	0.30	0.30	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	68.19	34.81	6.04	2.23	1.91	1.75	0.00	0.64	0.64
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	66.58	27.48	6.26	4.92	0.67	1.34	0.89	0.22	0.22
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	35.08	8.27	4.03	2.22	0.81	1.21	0.40	0.20	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	58.53	18.49	6.62	2.71	2.54	2.04	0.17	0.34	0.34
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	54.09	31.74	6.21	2.84	1.24	0.27	0.27	0.44	0.18
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	27.16	7.28	3.75	0.52	0.52	0.10	0.21	0.21	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	29.37	6.49	2.90	1.02	0.00	0.00	0.17	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	38.95	10.40	2.99	1.11	0.33	0.33	0.22	0.22	0.22
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	38.19	22.30	5.07	1.50	0.75	0.58	0.00	0.00	0.17
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	40.02	16.33	4.70	3.47	0.61	0.20	0.00	0.20	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	27.85	7.43	2.89	0.41	0.62	0.41	0.41	0.00	0.21
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	35.28	9.68	3.23	0.46	0.58	0.58	0.12	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	37.36	7.50	2.17	1.00	0.33	0.33	0.17	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	18.30	6.39	2.20	0.44	0.66	0.22	0.44	0.22	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	26.20	7.87	3.94	0.49	0.49	0.25	0.37	0.12	0.25
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	32.58	8.10	3.24	1.46	0.65	0.49	0.16	0.00	0.16
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	23.73	8.66	0.96	1.28	0.00	0.32	0.00	0.64	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	27.48	8.53	3.79	0.66	0.47	0.19	0.19	0.19	0.09
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	24.68	7.75	3.16	0.47	0.63	0.47	0.16	0.16	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	19.77	8.82	2.13	0.61	1.22	0.30	0.30	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	28.33	8.99	3.14	0.42	0.31	0.52	0.31	0.31	0.21
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	21.74	9.88	1.32	0.88	1.10	0.88	0.22	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	21.04	9.26	1.96	0.84	0.28	0.56	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	24.26	11.02	2.22	0.56	0.09	0.09	0.09	0.09	0.09
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	20.32	9.36	3.74	0.80	0.53	1.34	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	28.31	8.26	3.21	0.31	0.77	0.46	0.15	0.15	0.15
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	29.40	12.82	2.33	1.55	0.65	0.39	0.00	0.13	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	22.23	15.45	1.90	0.00	0.81	0.54	0.00	0.27	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	15.67	6.64	1.66	0.37	0.37	0.37	0.18	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	13.16	10.53	1.54	0.00	1.10	0.66	0.22	0.44	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	15.87	20.83	2.98	0.99	0.00	0.00	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	14.51	5.41	1.85	0.40	0.26	0.40	0.26	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	12.31	6.46	1.61	0.61	0.40	0.40	0.00	0.61	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	12.45	28.47	0.76	0.25	0.25	0.25	0.00	0.00	0.25
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	207.82	40.41	16.72	13.14	2.39	1.00	0.80	0.00	0.20
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	156.08	34.98	12.48	8.94	2.77	2.62	1.08	1.23	0.46
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	173.28	26.80	14.12	7.57	1.64	2.05	1.23	1.02	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	74.16	13.77	6.88	7.51	0.63	0.63	0.63	0.00	0.31
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	68.94	13.56	5.93	7.35	0.57	0.57	0.28	0.57	0.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	79.79	6.00	10.15	5.53	2.77	2.31	0.46	0.00	0.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	44.55	14.85	7.42	4.95	2.47	2.47	4.95	4.95	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	100.96	17.41	10.06	8.90	3.87	2.32	1.16	0.77	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	83.43	17.65	3.21	3.21	8.02	1.60	1.60	1.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	48.69	6.96	0.00	10.43	0.00	0.00	0.00	1.74	1.74
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	62.17	12.69	3.91	4.56	1.63	1.63	0.65	0.33	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	72.48	22.24	5.35	5.35	3.29	3.29	2.06	0.82	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	43.32	10.00	6.66	3.33	0.00	0.00	0.00	0.00	3.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	63.20	17.62	2.52	5.03	2.52	2.24	0.84	0.84	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	67.33	20.59	5.23	3.92	3.27	1.96	0.98	0.98	1.31
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	48.65	5.87	2.52	5.87	0.84	3.36	0.84	0.00	1.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	68.39	14.95	3.82	3.82	1.59	1.27	0.95	0.32	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	57.74	11.89	6.45	5.09	1.02	2.72	0.68	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	48.03	12.53	2.09	0.00	4.18	0.00	0.00	0.00	2.09
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	63.57	15.46	5.15	3.44	2.29	2.86	1.15	0.57	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	66.30	17.76	4.14	4.14	0.89	0.59	0.59	0.00	0.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	76.24	32.19	10.16	5.08	5.08	6.78	0.00	1.69	1.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	98.17	40.18	2.07	10.36	5.38	2.07	1.24	0.83	0.83
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	68.58	23.47	3.45	5.52	1.61	1.84	0.46	0.23	0.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	68.49	31.61	10.54	10.54	5.27	10.54	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	75.73	34.60	2.69	6.15	3.08	2.31	1.54	0.00	0.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	88.34	43.03	3.59	5.54	3.59	3.91	1.30	1.30	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	70.23	31.44	4.01	4.68	1.34	2.01	0.67	0.67	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	109.42	45.46	5.01	5.78	7.32	5.39	1.93	1.16	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	171.17	122.90	5.14	21.91	5.14	8.56	1.71	0.34	1.71
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	91.94	69.57	0.00	9.94	17.39	7.45	4.97	2.48	4.97
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	91.54	33.03	3.30	4.72	3.77	1.42	0.94	0.47	0.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	104.40	49.49	4.22	6.64	8.45	2.41	1.21	0.00	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	99.19	44.25	5.60	4.07	0.51	1.02	0.51	0.51	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	126.83	54.64	1.99	10.37	1.20	0.80	2.79	1.20	1.20
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	128.77	67.10	4.44	6.91	3.95	7.40	1.48	0.49	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	61.38	37.77	1.18	4.72	4.72	2.36	1.18	0.00	1.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	101.52	59.51	4.67	5.83	5.83	2.33	1.75	0.58	1.17
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	88.65	51.79	2.19	3.51	2.19	2.63	1.32	0.44	0.44
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	119.52	72.05	5.09	9.32	9.32	4.24	5.09	0.85	1.70
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	101.48	44.17	7.16	6.57	6.57	2.39	2.39	1.19	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	101.42	88.80	2.43	9.22	6.79	3.88	4.37	0.97	0.49
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	11.41	4.57	1.14	0.00	0.00	0.00	1.14	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	12.89	5.41	1.25	0.83	0.42	0.83	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	42.73	5.62	3.37	1.12	0.00	0.00	0.00	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	6.66	0.63	0.95	0.32	0.00	0.00	0.00	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	2.51	1.25	0.00	0.00	0.00	0.42	0.00	0.00	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	78.79	34.12	5.22	6.27	3.02	1.97	0.35	0.46	0.12
Hep-2 cells mock treated, biol_rep2	11899-125E9	88.62	39.84	5.23	9.62	3.38	1.86	0.84	0.51	0.34
Hep-2 cells mock treated, biol_rep3	11900-125F1	85.31	27.30	5.01	7.51	2.50	2.28	0.91	0.46	0.46
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	75.42	27.11	4.26	4.92	3.50	2.51	0.44	0.66	0.66
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	85.54	31.81	6.88	8.60	1.72	1.29	0.86	0.86	0.64
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	79.65	26.69	3.44	7.97	1.94	1.72	0.65	0.43	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	63.89	27.52	3.49	4.86	2.24	2.12	0.50	0.50	0.25
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	61.93	21.44	2.57	7.03	2.06	0.51	0.86	0.00	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	61.83	19.22	2.24	5.13	2.24	2.88	0.32	0.32	0.32
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	49.25	10.07	4.48	2.24	0.56	0.00	1.12	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	30.30	9.09	2.16	0.43	0.00	0.00	0.43	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	34.37	7.93	7.93	0.00	10.58	5.29	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	79.01	53.97	6.70	8.11	1.76	1.41	1.06	0.35	0.35
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	42.14	29.79	2.18	2.91	0.73	0.73	0.73	0.73	0.73
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	56.30	20.81	4.20	4.90	1.92	1.57	0.87	0.52	0.17
Hepatocyte, donor1	11523-119I2	21.79	7.26	2.42	1.21	1.21	0.00	0.00	0.00	1.21
Hepatocyte, donor2	11603-120I1	17.24	3.23	0.00	2.15	2.15	0.00	0.00	0.00	0.00
Hepatocyte, donor3	11684-122I1	19.63	5.52	1.23	3.07	1.84	1.84	0.00	1.23	0.61
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	29.37	1.96	5.87	1.31	0.00	0.00	0.00	0.00	0.65
Intestinal epithelial cells (polarized), donor1	11246-116E4	153.98	39.50	6.64	7.34	1.05	2.62	1.57	1.22	0.87
Iris Pigment Epithelial Cells, donor1	11530-119I9	57.08	43.22	5.08	3.02	0.41	0.82	0.41	0.14	0.14
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	47.76	0.00	6.37	3.18	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	40.05	0.00	13.35	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	27.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	60.91	2.77	4.15	4.15	0.00	1.38	1.38	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	50.05	2.50	0.00	2.50	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	59.34	0.00	11.87	11.87	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	89.70	7.69	12.81	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	41.14	0.00	4.57	9.14	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	56.85	0.00	6.50	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	38.35	3.33	0.00	3.33	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	58.09	3.63	0.00	7.26	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	48.97	1.32	6.62	2.65	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	84.26	5.54	5.54	4.43	1.11	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	52.38	0.00	5.24	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	53.54	4.41	6.93	3.15	0.63	0.63	0.00	0.00	0.63
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	81.97	6.19	4.64	3.09	1.55	0.00	1.55	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	73.17	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	63.31	1.94	3.88	1.94	0.65	0.00	0.00	0.65	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	74.06	4.83	6.44	8.05	0.00	0.00	0.00	0.00	1.61
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	71.69	11.95	11.95	11.95	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	48.08	2.44	2.44	1.63	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	54.16	2.94	3.78	2.52	0.00	0.00	0.42	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	14.37	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	53.85	5.63	5.63	2.41	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	69.25	3.69	4.62	3.69	0.00	0.92	0.00	0.00	0.92
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	75.40	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	53.34	2.36	2.83	4.72	0.47	0.47	0.47	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	72.56	2.72	2.72	4.53	1.81	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	73.71	14.74	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	57.03	4.30	2.15	3.23	2.15	1.08	1.08	1.08	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	73.69	11.43	5.08	7.62	0.00	0.00	0.00	0.00	1.27
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	32.86	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	63.13	4.46	5.74	3.83	0.00	0.64	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	76.55	1.82	5.47	5.47	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	31.61	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	59.27	4.28	9.28	5.00	0.00	0.00	0.71	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	39.82	3.32	3.32	3.32	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	83.39	20.85	0.00	20.85	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	69.14	5.25	9.26	2.16	1.85	0.93	0.31	0.62	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	87.80	1.76	8.78	3.51	0.00	1.76	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	53.43	0.00	3.14	12.57	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	65.37	2.78	6.26	4.17	0.00	0.00	0.00	0.70	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	73.03	2.21	8.85	2.21	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	74.57	6.48	0.00	6.48	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	40.11	1.74	5.23	0.00	0.00	0.87	0.00	0.87	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	60.74	4.50	4.50	0.00	0.00	2.25	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	31.36	10.45	3.48	3.48	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	51.21	5.33	1.07	0.00	1.07	1.07	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	52.65	0.00	6.93	4.16	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	59.84	5.70	2.85	2.85	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	48.78	2.76	2.76	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	51.43	6.05	3.03	9.08	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	55.88	6.21	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	45.47	3.17	5.29	2.11	1.06	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	53.20	49.78	5.30	3.43	1.55	1.71	0.65	0.49	0.49
Keratinocyte - epidermal, donor2	11349-117G8	45.09	21.67	2.93	7.03	0.59	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	89.54	34.93	6.44	4.64	1.99	1.99	0.66	0.66	0.66
Keratinocyte - oral, donor1	11251-116E9	106.71	55.40	9.08	3.29	2.38	1.59	0.91	0.34	0.45
Keratocytes, donor1	11527-119I6	104.87	7.91	10.66	3.44	0.69	0.34	0.69	0.00	0.00
Keratocytes, donor2	11607-120I5	29.30	2.34	2.34	2.34	0.00	1.17	0.00	0.00	0.00
Keratocytes, donor3	11688-122I5	18.38	1.78	2.77	0.79	0.40	0.20	0.00	0.40	0.40
Krukenberg tumor cell line:HSKTC	10687-109F3	76.93	48.35	10.99	2.20	2.20	2.20	0.00	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	59.33	24.81	4.31	7.55	3.24	3.24	0.00	0.00	0.00
Lens Epithelial Cells, donor2	11609-120I7	31.83	15.22	3.58	0.46	0.35	0.23	0.23	0.00	0.00
Lens Epithelial Cells, donor3	11690-122I7	29.87	20.18	2.62	0.71	0.10	0.00	0.00	0.10	0.20
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	24.43	4.62	4.74	0.59	0.12	0.71	0.36	0.12	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	19.54	4.19	0.84	0.28	1.12	0.56	0.28	0.28	0.28
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	18.57	5.19	2.05	0.16	2.05	1.42	0.16	0.31	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	16.67	3.76	1.61	0.00	0.54	0.54	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	16.07	1.89	3.78	0.32	0.00	0.00	0.00	0.32	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	16.50	5.07	2.59	0.22	1.40	0.75	0.11	0.32	0.11
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	14.36	4.92	4.10	1.23	0.41	0.00	0.41	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	14.66	4.55	1.26	0.51	0.25	0.25	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	16.05	5.07	3.24	0.14	0.84	0.56	0.14	0.14	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	14.63	3.16	2.37	0.00	0.79	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	16.48	3.10	2.33	0.00	0.00	0.58	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	14.81	4.07	1.48	0.37	0.56	0.37	0.37	0.56	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	18.12	3.83	2.44	0.35	0.35	1.05	0.35	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	15.74	4.29	1.43	0.48	0.24	0.24	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	16.07	4.67	2.33	0.41	0.96	0.82	0.14	0.14	0.14
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	18.48	4.00	1.23	0.31	0.00	0.31	0.31	0.31	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	11.53	3.74	2.81	0.31	0.62	0.31	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	19.58	4.57	1.46	0.00	0.73	0.55	0.37	0.18	0.18
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	18.43	3.29	2.63	0.66	0.33	0.66	0.33	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	14.94	4.39	1.46	0.29	1.46	0.29	0.88	0.00	0.29
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	12.45	2.99	1.99	0.00	0.25	0.50	0.50	0.50	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	19.40	2.91	1.94	0.48	0.48	0.97	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	14.27	4.58	2.15	0.81	0.27	0.00	0.00	0.27	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	17.71	6.36	2.12	0.30	0.76	0.61	0.15	0.00	0.15
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	9.85	8.29	1.56	0.52	0.52	0.52	1.04	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	12.77	1.88	3.14	0.21	1.26	0.84	0.21	0.21	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	14.29	3.46	1.35	0.00	0.90	0.75	0.00	0.15	0.15
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	18.57	5.50	2.75	0.69	0.00	0.69	0.69	0.00	0.69
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	15.24	4.14	2.26	0.56	0.75	0.38	0.00	0.19	0.19
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	20.04	3.50	3.07	0.53	1.17	0.85	0.11	0.53	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	16.96	4.36	3.39	0.97	1.94	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	17.86	5.62	1.65	0.66	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	17.10	5.33	2.48	0.50	0.50	1.49	0.37	0.37	0.37
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	19.62	5.55	1.48	0.74	0.37	0.37	0.00	0.37	0.74
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	14.58	4.45	1.73	0.25	0.25	0.25	0.00	0.00	0.25
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	18.42	3.85	2.06	0.69	0.55	0.82	0.00	0.14	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	21.55	3.54	3.22	0.32	0.32	0.32	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	14.00	7.00	1.83	0.00	0.61	0.30	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	17.78	5.60	1.82	0.00	1.26	0.42	0.28	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	17.42	4.98	2.13	0.36	0.71	0.71	0.36	0.36	0.71
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	11.63	2.42	3.88	0.97	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	16.03	4.82	1.71	0.31	1.09	0.47	0.16	0.16	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	21.13	6.09	2.15	0.72	1.43	1.07	0.00	0.36	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	16.66	4.25	1.96	0.00	0.65	0.65	0.00	0.00	0.33
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	14.83	4.24	1.41	0.47	0.94	0.71	0.71	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	34.03	8.42	3.34	0.62	0.37	0.74	0.00	0.25	0.12
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	13.32	4.35	2.82	0.26	0.26	0.51	0.00	0.00	0.26
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	26.85	5.37	2.09	0.30	1.19	0.30	0.30	0.30	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	27.19	15.86	13.60	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	53.70	13.04	1.53	3.84	1.53	0.00	0.77	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	36.37	10.39	1.48	4.45	0.00	0.74	0.74	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	27.08	13.96	0.85	2.12	1.27	2.12	1.27	1.69	0.42
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	35.87	16.88	0.70	2.11	0.70	0.70	0.00	0.70	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	33.62	8.41	0.93	3.74	0.00	2.80	0.93	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	30.40	13.40	2.06	3.09	4.12	1.55	0.52	1.03	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	44.01	11.89	3.57	3.57	1.19	0.00	2.38	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	29.63	16.06	2.94	1.58	0.23	0.23	0.00	0.00	0.23
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	41.88	15.41	3.49	4.07	3.20	2.91	0.87	0.58	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	49.07	21.16	2.70	3.15	2.25	0.45	1.35	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	39.43	19.92	3.66	5.01	0.68	0.14	0.14	0.14	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	28.24	14.38	1.03	3.08	0.51	1.03	0.00	1.03	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	49.05	20.11	1.76	4.94	1.06	1.06	0.35	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	33.98	9.33	2.67	4.66	0.67	0.67	1.33	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	30.05	14.77	3.57	2.55	2.55	2.55	0.51	0.51	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	62.17	21.34	3.74	4.00	2.40	0.27	1.07	0.53	0.53
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	57.82	25.51	2.27	3.21	3.21	0.76	1.13	0.38	0.19
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	32.52	17.79	4.91	3.68	2.45	0.00	1.23	0.61	1.23
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	54.63	13.86	4.08	2.45	2.45	0.82	1.63	0.82	2.45
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	59.97	21.66	2.71	3.12	4.16	2.08	2.08	1.25	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	40.36	16.54	1.96	1.96	3.36	3.36	3.08	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	63.88	25.76	1.03	3.09	2.06	0.00	1.03	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	54.00	24.68	1.45	2.32	3.19	1.16	1.45	0.58	0.29
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	37.07	14.05	3.29	4.19	2.09	0.30	0.30	1.20	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	62.52	21.02	1.66	4.43	3.32	1.66	1.66	0.55	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	57.97	23.68	2.12	3.53	1.77	2.83	0.35	1.06	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	38.35	16.60	2.21	5.16	2.21	2.21	2.21	0.37	0.37
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	48.35	11.51	1.15	5.76	3.45	2.30	0.00	1.15	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	51.81	29.17	2.30	4.99	1.15	0.77	1.92	0.38	0.77
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	33.97	10.76	1.70	2.83	1.70	1.70	3.96	0.57	1.13
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	63.18	18.87	0.00	5.74	0.00	0.82	0.00	0.82	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	49.71	22.59	0.45	2.71	3.16	0.90	1.36	0.00	0.45
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	45.24	22.98	2.87	3.59	2.87	0.72	1.44	0.72	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	64.23	20.17	2.24	5.23	1.49	1.49	0.00	0.00	0.75
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	65.03	29.73	4.83	4.09	4.83	2.23	2.60	0.37	0.37
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	36.61	21.97	2.15	3.02	1.29	0.43	0.43	0.43	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	61.65	24.83	1.71	4.28	0.86	0.00	2.57	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	63.30	28.32	4.00	5.00	4.00	3.00	0.33	1.67	0.33
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	53.09	20.51	7.24	2.41	2.41	2.41	0.00	0.00	0.60
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	59.72	19.20	4.98	4.27	0.71	1.42	0.71	0.71	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	46.40	18.56	2.06	4.81	2.41	2.06	0.34	1.03	0.69
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	41.33	12.35	1.61	2.15	1.07	0.54	1.61	0.00	1.07
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	49.16	8.08	0.00	2.02	0.67	0.67	0.67	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	50.38	18.15	1.11	2.59	3.33	2.22	1.48	1.11	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	55.82	11.63	3.49	2.33	1.16	1.16	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	41.25	20.10	0.00	4.23	1.06	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	50.42	19.61	2.80	1.60	2.00	1.20	2.80	0.00	0.40
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	31.26	13.08	2.18	9.45	1.45	1.45	1.45	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	54.42	21.46	7.67	6.90	2.30	0.00	0.00	1.53	0.77
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	44.39	20.72	2.47	4.93	2.47	1.48	0.99	0.49	0.49
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	32.93	15.05	3.76	0.94	1.88	0.00	0.00	0.94	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	53.30	18.10	2.01	6.03	1.51	2.51	0.50	0.00	1.01
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	45.06	18.48	3.60	4.51	2.25	0.90	0.90	0.45	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	20.65	25.82	1.72	5.16	1.72	1.72	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	55.67	30.73	4.01	3.56	0.89	1.78	0.89	0.89	1.34
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	57.48	17.99	4.69	6.26	2.35	1.96	1.17	0.39	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	22.43	17.15	1.32	4.62	1.98	0.66	0.00	0.66	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	55.53	29.58	1.04	7.78	0.52	2.59	1.04	0.52	1.04
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	66.51	29.75	4.81	4.38	4.81	0.88	0.88	0.44	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	46.41	23.48	1.68	3.91	0.56	2.24	1.12	1.68	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	56.09	22.97	2.21	5.30	1.77	0.44	2.65	0.88	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	58.63	30.47	3.86	4.63	2.31	2.31	1.54	0.39	0.39
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	38.48	18.23	3.54	3.04	4.05	1.52	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	83.63	37.97	0.96	3.36	5.29	0.96	0.00	0.96	0.48
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	58.84	32.60	2.78	5.96	1.59	1.19	0.40	0.40	1.19
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	44.96	27.34	3.04	4.86	1.22	0.00	0.61	0.00	1.22
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	47.73	15.22	1.38	6.92	1.38	0.00	0.00	0.00	0.69
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	59.28	30.40	4.18	4.56	1.90	2.28	1.52	0.76	1.52
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	40.80	26.34	3.61	4.13	3.61	2.58	2.58	1.03	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	50.79	19.35	1.81	2.42	1.21	0.00	0.60	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	59.58	29.79	2.85	4.12	1.27	0.95	2.22	0.63	0.32
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	38.38	19.19	3.20	3.73	2.13	1.60	1.07	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	45.97	18.96	2.87	8.05	1.15	0.00	0.57	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	57.08	26.23	3.09	4.63	8.23	2.57	2.57	0.00	0.51
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	41.73	31.83	2.83	7.78	2.83	2.12	2.83	2.12	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	62.42	21.00	2.84	6.81	3.40	0.00	0.00	0.00	1.70
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	53.67	21.22	4.58	5.41	4.58	2.50	1.25	0.00	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	40.72	38.37	0.78	8.61	3.92	0.78	2.35	0.78	0.78
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	58.04	38.83	1.67	9.60	2.51	0.42	1.25	0.42	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	66.91	35.78	4.18	4.18	3.25	1.86	2.79	0.93	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	56.20	30.11	2.68	4.01	2.01	2.68	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	79.13	32.08	3.74	6.42	3.21	0.53	1.07	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	82.03	57.79	4.45	7.68	3.64	4.04	3.64	1.62	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	41.30	21.11	1.84	2.75	2.75	0.92	0.92	0.00	0.92
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	75.57	27.56	0.89	10.67	5.33	0.89	0.89	0.00	0.89
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	80.92	42.74	2.28	4.56	1.71	1.14	1.14	0.57	0.57
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	39.88	22.24	2.30	0.00	0.77	0.77	0.77	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	50.89	16.42	2.19	6.02	1.09	0.00	1.09	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	73.94	36.08	4.01	4.01	2.23	0.45	1.34	0.00	0.45
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	49.91	23.14	2.86	1.82	1.30	0.00	0.00	0.00	0.26
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	35.81	17.90	3.32	5.30	1.33	2.65	1.33	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	35.34	10.39	4.16	2.08	4.16	4.16	0.00	0.00	2.08
Macrophage - monocyte derived, donor1	11232-116C8	19.14	14.13	3.19	0.46	0.68	0.23	0.23	0.00	0.00
Macrophage - monocyte derived, donor2	11313-117C8	26.43	8.44	2.75	1.10	0.37	0.37	0.00	0.18	0.00
Macrophage - monocyte derived, donor3	11389-118C3	35.92	10.22	2.88	1.97	1.31	0.52	0.13	0.13	0.13
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	43.01	35.05	3.72	4.78	0.00	0.53	1.06	0.00	0.53
Mallassez-derived cells, donor2	11929-125I3	96.02	96.81	4.75	15.53	2.69	1.58	2.38	1.11	0.16
Mallassez-derived cells, donor3	11930-125I4	94.93	43.36	6.25	7.09	0.69	0.56	0.83	0.56	0.14
Mammary Epithelial Cell, donor1	11273-116H4	122.56	53.11	7.47	5.88	2.99	1.99	0.90	0.90	0.40
Mammary Epithelial Cell, donor2	11350-117G9	107.71	24.32	8.69	10.42	3.47	0.87	0.58	0.58	0.29
Mammary Epithelial Cell, donor3	11422-118F9	136.94	33.42	7.23	4.49	1.25	0.50	0.25	0.25	0.25
Mast cell - stimulated, donor1	11487-119E2	157.28	223.72	14.91	5.42	0.68	0.00	0.00	1.36	0.00
Mast cell, donor1	11563-120D6	34.06	19.25	5.19	0.87	0.22	0.11	0.11	0.11	0.11
Mast cell, donor2	11565-120D8	70.13	117.98	10.70	12.78	0.89	0.89	0.00	0.00	0.59
Mast cell, donor3	11566-120D9	72.94	32.42	13.28	8.55	0.23	0.00	0.00	0.00	0.00
Mast cell, donor4	11567-120E1	99.81	59.92	6.91	17.37	0.18	0.53	0.00	0.00	0.00
Mast cell, expanded and stimulated, donor5	11940-126A5	33.27	20.85	5.77	1.22	0.55	0.22	0.22	0.22	0.11
Mast cell, expanded and stimulated, donor8	11942-126A7	7.59	9.92	2.33	0.00	0.00	0.58	0.00	0.00	0.58
Mast cell, expanded, donor5	11939-126A4	27.65	17.32	3.90	1.49	0.46	0.11	0.11	0.11	0.11
Mast cell, expanded, donor8	11941-126A6	16.07	16.40	2.51	0.50	0.33	0.17	0.17	0.17	0.00
Melanocyte - dark, donor1	11502-119F8	33.03	6.37	3.88	1.39	0.20	0.00	0.00	0.20	0.00
Melanocyte - dark, donor2	11582-120F7	21.46	1.73	1.04	1.73	0.35	1.38	0.00	0.35	0.00
Melanocyte - dark, donor3	11663-122F7	24.48	3.26	3.33	0.65	0.07	0.43	0.14	0.00	0.07
Melanocyte - light, donor1	11274-116H5	16.93	7.52	1.41	0.47	0.47	0.71	0.00	0.00	0.00
Melanocyte - light, donor2	11351-117H1	20.47	9.55	2.05	0.00	0.00	0.00	0.68	0.00	0.00
Melanocyte - light, donor3	11423-118G1	13.88	13.01	1.73	0.00	0.87	0.87	0.00	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	58.00	24.16	5.00	3.12	1.15	0.94	0.10	0.21	0.31
Melanocyte, donor2 (MC+2)	12739-135I3	15.87	7.53	2.42	0.00	0.54	0.27	0.54	0.27	0.27
Melanocyte, donor3 (MC+3)	12837-137B2	35.09	27.59	1.87	1.34	0.27	0.27	0.80	0.54	0.00
Meningeal Cells, donor1	11493-119E8	83.24	5.71	9.30	4.34	0.12	0.00	0.12	0.00	0.00
Meningeal Cells, donor2	11573-120E7	46.66	3.96	2.64	2.64	0.00	0.00	0.44	0.00	0.00
Meningeal Cells, donor3	11654-122E7	35.21	3.99	5.71	1.47	0.49	0.57	0.33	0.16	0.08
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	33.08	9.98	3.99	1.14	0.86	0.29	0.00	0.00	0.29
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	10.37	10.97	0.10	0.81	0.10	0.10	0.00	0.10	0.00
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	1.31	1.31	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	17.01	1.31	1.31	1.31	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	23.68	0.72	2.87	0.00	0.00	2.15	0.00	0.72	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	36.85	24.35	2.33	3.39	1.06	1.06	0.85	0.00	0.00
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	54.29	34.68	2.01	7.04	1.01	1.01	0.00	0.00	0.50
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	30.77	8.79	4.61	2.64	0.66	0.22	0.22	0.44	0.00
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	68.68	11.69	2.92	2.19	0.00	0.00	0.73	0.00	0.73
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	20.66	10.84	2.25	0.61	0.20	0.82	0.00	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	4.16	5.96	1.25	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	36.06	28.25	2.60	5.20	1.12	0.74	0.37	0.00	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	34.34	16.45	2.89	1.32	1.05	0.53	0.00	0.13	0.00
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	7.12	13.65	0.59	0.89	0.30	0.30	0.59	0.00	0.30
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	2.34	2.34	0.00	0.00	0.00	0.00	0.00	2.34	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	20.49	6.40	2.56	0.64	1.28	0.00	0.00	0.00	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	25.87	1.77	1.42	0.00	0.35	0.35	0.00	0.00	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	36.28	19.08	4.07	2.50	1.56	0.00	0.63	0.00	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	42.09	2.18	3.63	0.73	0.00	0.00	0.00	0.00	0.00
Mesothelial Cells, donor1	11247-116E5	249.53	393.52	6.89	22.81	4.77	2.92	3.45	1.06	2.39
Mesothelial Cells, donor2	12156-128G5	121.61	256.74	4.50	5.00	4.00	1.50	2.00	0.50	0.50
Mesothelial Cells, donor3	11402-118D7	309.94	439.30	4.70	32.66	15.54	10.04	8.17	7.01	3.76
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	9.45	5.40	1.35	1.35	1.35	0.00	1.35	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	18.72	8.62	1.48	0.74	0.49	0.00	0.25	0.25	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	15.02	9.13	2.65	0.59	0.29	0.29	0.00	0.29	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	13.95	7.13	1.24	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	16.39	11.20	1.45	0.41	0.83	0.21	0.21	0.21	0.21
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	2.32	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	22.52	9.51	1.50	0.50	0.50	0.25	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	19.08	9.78	2.79	0.47	0.00	0.93	0.47	0.00	0.47
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	17.48	8.33	2.03	0.41	0.41	0.00	0.20	0.20	0.20
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	12.67	10.30	1.19	0.79	0.00	0.40	0.00	0.40	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	8.55	17.10	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	10.62	8.85	1.77	0.00	0.00	0.00	0.88	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	16.72	10.64	0.76	1.14	0.76	0.76	0.38	0.38	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	2.63	1.32	1.32	1.32	0.00	0.00	0.00	0.00	1.32
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	15.49	9.55	1.49	0.64	0.21	0.21	0.21	0.00	0.21
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	11.97	9.21	0.92	0.92	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	13.71	5.96	0.00	0.00	0.30	0.60	0.60	0.30	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	5.03	5.03	0.00	1.68	0.00	0.00	1.68	0.00	1.68
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	14.30	16.81	1.25	1.51	0.75	1.00	0.75	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	18.06	9.03	1.90	0.00	0.24	0.24	0.00	0.24	0.24
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	8.85	3.87	0.55	0.00	0.00	0.00	1.11	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	24.18	13.12	1.15	0.69	0.00	0.69	1.38	0.23	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	19.98	13.46	2.31	1.05	0.63	0.00	0.21	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	19.98	8.97	2.45	1.83	0.82	0.61	0.20	0.00	0.20
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	19.09	13.30	1.72	1.29	0.21	0.21	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	19.34	12.23	1.33	1.11	0.00	0.44	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	10.32	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	19.27	14.46	1.31	0.22	0.44	0.66	0.00	0.00	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	15.21	13.69	1.52	1.52	0.51	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	6.63	3.31	1.66	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	19.03	13.59	2.45	1.36	0.00	0.54	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	19.70	11.76	1.76	0.59	0.59	0.00	0.29	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	8.72	4.36	1.09	0.00	1.09	1.09	1.09	1.09	1.09
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	24.99	13.46	1.44	0.96	0.96	0.96	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	19.61	12.01	2.80	0.00	0.40	0.40	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	23.31	1.37	1.37	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	24.03	14.02	1.50	1.50	0.00	0.50	0.50	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	12.23	6.12	4.08	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	27.59	9.63	2.19	1.31	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	17.66	9.93	5.52	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	17.29	7.68	3.20	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	27.77	15.12	1.49	1.49	0.25	0.00	0.74	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	18.09	11.83	2.78	0.70	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	8.84	6.63	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	23.25	8.21	3.08	2.74	1.37	0.34	0.34	0.34	0.34
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	21.88	9.63	2.19	0.44	0.00	0.88	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	17.04	5.68	1.78	0.71	0.36	0.00	0.36	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	29.46	9.54	1.96	2.81	0.56	0.56	0.56	0.28	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	25.77	8.73	0.83	0.83	0.00	0.00	0.00	0.42	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	17.48	6.99	0.58	0.58	0.00	0.00	0.00	0.58	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	14.78	8.14	1.51	1.21	0.90	0.00	0.30	0.30	0.30
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	21.70	9.60	2.09	1.67	0.42	0.00	0.42	0.00	0.42
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	7.22	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	12.01	4.62	1.85	0.00	0.00	0.00	0.00	0.92	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	30.16	15.94	2.85	1.14	1.71	0.00	0.57	0.57	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	19.07	7.19	2.21	0.69	0.14	0.28	0.14	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	22.29	5.44	1.30	1.55	0.26	0.26	0.26	0.52	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	25.74	14.59	3.00	0.86	0.86	0.43	0.43	0.00	0.43
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	8.26	4.45	2.54	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	13.08	5.07	1.60	0.27	0.27	0.53	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	20.65	12.27	2.10	1.20	0.00	0.00	0.90	0.00	0.30
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	11.16	4.38	1.41	0.28	0.14	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	21.34	5.10	1.27	0.32	0.32	0.32	0.00	0.00	0.64
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	27.86	11.28	1.55	1.99	1.11	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	13.65	3.03	1.90	0.38	0.00	0.00	0.76	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	21.59	2.84	0.85	1.14	0.00	0.00	0.00	0.28	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	26.55	10.82	2.46	1.23	0.49	0.25	0.25	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	9.78	1.96	0.00	0.00	0.00	0.00	0.65	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	12.94	4.12	1.18	0.59	0.29	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	22.49	8.94	1.73	0.58	0.58	0.00	0.58	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	12.78	4.53	2.47	0.41	0.00	0.00	0.41	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	10.72	3.28	0.89	0.00	0.00	0.30	0.00	0.00	0.30
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	11.30	3.77	3.77	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	8.91	3.56	1.78	1.78	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	14.13	5.59	1.64	0.00	0.00	0.33	0.00	0.33	0.33
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	19.99	6.31	1.05	1.05	1.05	3.16	0.00	0.00	1.05
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	7.51	7.12	1.38	0.59	0.20	0.20	0.20	0.00	0.20
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	9.31	6.52	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	9.01	5.26	1.50	1.13	0.75	0.00	0.75	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	15.18	4.00	1.07	1.07	0.53	0.00	0.27	0.00	0.27
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	15.83	8.26	1.47	0.34	0.68	0.11	0.11	0.11	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	10.31	1.47	0.74	0.74	0.74	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	10.26	5.13	0.37	0.37	1.10	0.73	0.37	0.00	0.37
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	17.11	7.78	1.56	1.56	1.56	1.56	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	13.90	8.55	1.60	1.07	0.00	0.53	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	0.00	7.73	0.00	0.00	0.00	0.00	3.86	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	11.11	10.10	2.02	1.01	2.02	1.01	0.00	0.00	1.01
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	18.13	5.06	1.69	0.42	0.42	0.00	0.42	0.42	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	2.72	20.43	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	5.09	6.99	1.27	1.27	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	4.05	6.48	0.81	1.62	0.00	0.00	0.00	0.81	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	4.53	10.57	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	11.42	85.65	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	22.84	205.53	6.52	6.52	0.00	0.00	3.26	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	9.50	61.78	0.00	4.75	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	0.00	37.65	0.00	12.55	0.00	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	18.74	9.69	1.94	1.08	0.43	0.65	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	16.72	8.36	2.09	0.52	0.52	0.52	0.00	0.52	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	17.35	7.34	2.00	0.00	0.00	0.00	0.00	0.67	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	10.43	7.10	1.67	0.42	0.00	0.00	0.42	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	30.61	8.94	3.23	1.33	0.57	0.57	0.00	0.38	0.00
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	27.13	6.38	3.19	0.00	1.60	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	2.72	2.72	0.00	0.00	0.00	0.00	0.68	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	23.89	12.86	7.35	1.84	3.68	1.84	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	3.77	2.93	0.42	0.42	0.00	0.84	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	15.34	7.44	0.93	0.46	0.00	0.46	0.23	0.23	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	6.49	3.24	1.62	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	13.88	5.47	2.10	0.63	0.42	0.21	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	66.81	22.27	11.13	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	5.46	2.98	0.00	0.00	0.00	0.00	0.50	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	7.04	4.33	0.00	0.54	0.27	0.00	0.27	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	6.35	5.44	0.68	0.45	0.45	0.68	0.00	0.00	0.23
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	3.92	1.63	0.33	0.00	0.00	0.16	0.00	0.00	0.16
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	9.48	4.01	0.36	0.36	0.91	0.00	0.00	0.00	0.18
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	4.24	5.30	0.53	0.53	0.00	0.00	0.53	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	2.40	3.00	0.60	0.00	0.00	0.60	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	8.53	5.25	0.98	0.00	0.33	0.00	0.33	0.00	0.33
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	4.55	2.93	0.16	0.49	0.00	0.00	0.16	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	9.52	6.53	0.53	0.35	0.35	0.00	0.00	0.18	0.00
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	1.41	2.81	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	0.46	1.38	0.46	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	4.82	3.86	0.96	0.00	0.00	0.32	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	11.38	10.69	0.69	1.03	0.34	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	37.93	17.70	0.00	0.00	2.53	2.53	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	8.24	6.91	0.22	0.00	0.00	0.22	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	2.54	5.93	0.42	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	5.22	4.27	1.19	0.00	0.00	0.00	0.24	0.47	0.24
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	6.01	4.72	2.15	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	18.06	0.00	0.00	9.03	0.00	9.03	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	3.67	3.33	0.00	0.67	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	4.96	4.96	1.80	0.90	0.45	0.00	0.00	0.00	0.45
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	3.97	1.98	0.79	0.79	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	6.50	3.71	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	9.46	4.54	0.76	0.00	0.00	0.38	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	5.87	3.91	0.33	0.33	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	3.49	0.87	0.44	0.00	0.00	0.44	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	5.88	10.40	0.90	0.90	0.00	0.00	0.00	0.00	0.45
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	5.29	2.65	0.00	0.88	0.88	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	1.33	0.66	0.00	0.66	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	5.95	1.98	0.50	0.00	0.50	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	3.83	3.83	0.38	0.00	0.38	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	5.44	7.86	0.30	0.00	0.30	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	9.95	9.95	0.44	0.22	0.00	0.00	0.00	0.00	0.22
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	2.03	2.03	0.00	0.68	0.00	0.00	0.00	0.68	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	2.44	4.27	0.00	0.00	0.00	0.61	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	4.09	5.04	0.00	0.00	0.00	0.63	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	2.42	2.42	0.00	0.00	0.30	0.30	0.00	0.00	0.30
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	5.54	3.96	0.00	0.00	0.00	0.79	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	6.80	3.40	0.00	0.00	0.00	1.13	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	10.12	5.06	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	8.94	5.96	1.12	0.75	0.12	0.50	0.12	0.00	0.00
Myoblast, donor2	11322-117D8	18.80	18.99	2.49	0.77	2.11	1.92	0.00	0.00	0.19
Myoblast, donor3	11398-118D3	22.03	13.45	1.85	1.18	0.34	0.17	0.00	0.17	0.17
NK T cell leukemia cell line:KHYG-1	10777-110G3	181.83	60.12	9.05	8.03	4.23	3.21	2.19	1.46	0.88
Natural Killer Cells, donor1	11230-116C6	114.70	123.93	9.53	23.68	1.85	3.08	0.00	0.31	1.54
Natural Killer Cells, donor2	11311-117C6	135.40	179.12	9.35	30.76	3.62	3.62	2.41	1.51	0.90
Natural Killer Cells, donor3	11387-118C1	128.10	103.81	6.81	35.52	1.29	3.50	0.55	0.74	0.55
Neural stem cells, donor1	11275-116H6	68.96	75.85	9.80	2.54	0.00	1.09	0.73	0.36	0.00
Neural stem cells, donor2	11352-117H2	102.06	213.75	15.41	13.48	0.00	0.00	3.85	0.00	0.00
Neurons, donor1	11494-119E9	137.69	175.24	11.38	6.83	6.83	4.55	0.00	2.28	0.00
Neurons, donor2	11574-120E8	74.86	84.98	8.59	4.40	1.32	1.54	0.44	0.66	0.44
Neurons, donor3	11655-122E8	83.04	139.77	7.40	2.47	4.93	4.93	1.64	2.47	2.47
Neutrophils, donor1	11233-116C9	19.49	4.64	3.71	0.00	0.00	0.93	0.00	0.00	0.00
Neutrophils, donor2	11314-117C9	20.29	2.90	0.00	0.00	2.90	0.00	0.00	0.00	2.90
Neutrophils, donor3	11390-118C4	43.98	14.05	5.50	1.22	0.00	0.00	0.00	0.00	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	8.19	4.99	1.78	0.24	0.12	0.59	0.00	0.00	0.00
Nucleus Pulposus Cell, donor2	11409-118E5	7.16	2.60	0.33	0.00	0.00	0.00	0.00	0.33	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	11.23	4.21	0.80	0.40	0.20	0.40	0.00	0.00	0.00
Olfactory epithelial cells, donor1	11933-125I7	20.92	6.19	1.65	1.10	1.24	0.69	0.14	0.00	0.41
Olfactory epithelial cells, donor2	11934-125I8	41.11	21.13	2.61	3.18	4.34	2.03	0.72	2.32	0.87
Olfactory epithelial cells, donor3	11935-125I9	25.20	12.03	0.79	1.48	1.14	0.68	0.23	0.45	0.00
Olfactory epithelial cells, donor4	11936-126A1	20.06	4.68	1.17	0.39	0.78	0.88	0.39	0.29	0.19
Oligodendrocyte - precursors, donor1	11496-119F2	204.02	210.64	6.02	20.46	3.61	1.81	0.60	0.00	0.60
Osteoblast - differentiated, donor1	11276-116H7	8.51	13.19	1.49	0.00	0.00	0.21	0.43	0.00	0.00
Osteoblast - differentiated, donor2	11353-117H3	2.29	10.29	0.00	1.14	0.00	0.00	0.00	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	13.03	7.45	1.86	0.00	0.62	0.00	1.24	0.00	0.00
Osteoblast, donor1	11277-116H8	30.68	21.30	3.71	2.54	0.78	0.20	0.20	0.39	0.00
Osteoblast, donor2	11354-117H4	57.59	28.80	5.62	4.92	0.70	1.40	0.70	0.00	0.00
Osteoblast, donor3	11426-118G4	47.45	25.59	3.20	1.60	0.53	0.71	0.00	0.36	0.18
Pancreatic stromal cells, donor1	11249-116E7	29.74	6.74	2.70	1.26	0.76	0.42	0.17	0.17	0.00
Pericytes, donor1	11491-119E6	8.57	6.45	0.11	0.56	0.00	0.00	0.11	0.00	0.00
Pericytes, donor2	11571-120E5	8.60	5.89	0.45	0.45	0.00	0.23	0.00	0.00	0.00
Pericytes, donor3	11652-122E5	33.77	12.41	1.02	2.24	0.61	0.20	0.00	0.20	0.41
Perineurial Cells, donor1	11499-119F5	30.52	5.88	4.18	1.13	0.34	0.23	0.00	0.11	0.11
Perineurial Cells, donor2	11579-120F4	26.68	3.59	2.48	1.01	0.18	0.00	0.09	0.00	0.09
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	97.22	105.18	10.20	14.34	0.96	0.32	0.00	0.64	0.00
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	97.70	53.14	5.39	21.30	2.20	1.96	0.98	0.73	0.24
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	135.76	69.63	6.60	13.46	1.94	1.42	0.39	0.39	0.13
Placental Epithelial Cells, donor1	11278-116H9	115.04	138.72	2.63	7.65	3.11	2.63	0.96	0.24	0.24
Placental Epithelial Cells, donor2	11355-117H5	87.60	87.60	4.44	7.76	0.00	1.11	1.11	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	141.55	96.20	4.91	7.07	2.75	1.57	0.39	0.59	0.20
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	12.03	2.53	0.63	0.00	0.00	0.95	0.32	0.00	0.00
Preadipocyte - breast, donor1	11467-119B9	3.19	2.06	0.38	0.00	0.00	0.00	0.00	0.00	0.00
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	42.42	26.63	2.09	1.83	0.78	0.13	0.00	0.39	0.13
Preadipocyte - breast, donor2	11328-117E5	10.36	7.66	1.35	0.68	0.23	0.45	0.68	0.00	0.23
Preadipocyte - omental, donor1	11468-119C1	5.43	4.05	0.75	0.11	0.11	0.11	0.32	0.00	0.00
Preadipocyte - omental, donor2	11329-117E6	12.22	7.42	1.31	0.87	0.44	0.44	0.00	0.00	0.00
Preadipocyte - omental, donor3	11403-118D8	13.75	6.59	0.86	0.57	0.57	0.14	0.43	0.00	0.00
Preadipocyte - perirenal, donor1	11469-119C2	9.84	6.89	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	15.97	1.84	0.61	0.31	0.00	0.00	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	22.13	1.77	2.48	0.53	0.89	0.18	0.53	0.35	0.00
Preadipocyte - subcutaneous, donor3	11428-118G6	7.66	0.85	0.85	0.51	0.00	0.17	0.00	0.17	0.00
Preadipocyte - visceral, donor1	11280-116I2	26.55	1.68	2.51	0.65	0.28	0.28	0.19	0.00	0.00
Preadipocyte - visceral, donor2	11357-117H7	29.91	2.76	2.76	1.38	0.92	0.00	0.46	0.00	0.46
Preadipocyte - visceral, donor3	11429-118G7	14.84	0.63	2.82	0.73	0.42	0.31	0.21	0.10	0.00
Prostate Epithelial Cells (polarized), donor1	11253-116F2	117.36	26.85	6.03	9.65	2.56	1.51	0.30	0.60	0.15
Prostate Epithelial Cells, donor2	11331-117E8	53.22	64.46	3.93	5.96	3.52	1.62	1.22	0.95	0.54
Prostate Epithelial Cells, donor3	11404-118D9	49.97	47.03	1.96	2.82	2.33	1.53	0.61	0.98	0.43
Prostate Stromal Cells, donor1	11254-116F3	68.91	45.79	4.78	3.30	1.59	1.48	0.57	0.34	0.34
Prostate Stromal Cells, donor2	11332-117E9	67.06	24.92	5.56	2.51	2.87	2.15	0.90	1.08	0.72
Prostate Stromal Cells, donor3	11405-118E1	19.71	16.16	1.15	1.04	0.83	0.63	0.10	0.73	0.21
Renal Cortical Epithelial Cells, donor1	11516-119H4	113.87	91.98	5.47	10.22	1.46	0.73	1.82	0.00	1.09
Renal Cortical Epithelial Cells, donor2	11596-120H3	100.29	126.63	7.62	6.38	2.70	2.70	1.04	0.76	0.14
Renal Epithelial Cells, donor1	11517-119H5	47.68	26.38	3.55	2.54	0.51	0.00	0.00	0.00	0.00
Renal Epithelial Cells, donor2	11597-120H4	97.45	39.83	3.56	4.98	4.27	1.42	0.71	0.00	0.71
Renal Epithelial Cells, donor3	11678-122H4	64.37	40.65	7.52	2.96	1.38	1.27	0.74	0.64	0.21
Renal Glomerular Endothelial Cells, donor1	11514-119H2	53.79	10.21	4.77	2.72	0.68	0.00	0.68	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	51.75	11.86	4.45	2.43	0.40	1.21	0.54	0.00	0.27
Renal Glomerular Endothelial Cells, donor3	11675-122H1	90.36	21.09	8.21	4.66	2.66	3.11	1.55	0.22	1.33
Renal Glomerular Endothelial Cells, donor4	11783-124B1	19.96	6.65	0.00	0.00	0.67	0.00	0.00	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	77.03	51.72	5.72	7.04	1.98	1.32	0.66	0.00	0.00
Renal Mesangial Cells, donor2	11598-120H5	98.44	44.52	5.64	6.27	0.63	0.63	0.00	0.00	0.00
Renal Mesangial Cells, donor3	11679-122H5	49.10	27.46	2.50	1.94	0.83	0.28	0.83	0.55	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	191.65	196.22	19.59	17.98	3.22	2.15	2.15	0.27	0.27
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	123.98	85.18	6.75	9.70	5.90	5.48	2.11	1.27	0.84
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	132.10	74.82	6.75	4.24	2.89	1.74	1.16	0.77	0.77
Retinal Pigment Epithelial Cells, donor0	11215-116A9	100.60	96.97	8.04	4.15	2.33	1.81	1.04	0.52	0.26
Retinal Pigment Epithelial Cells, donor1	11528-119I7	108.01	129.90	8.24	9.66	2.84	3.13	0.85	0.85	0.57
Retinal Pigment Epithelial Cells, donor2	11608-120I6	51.46	22.64	0.00	3.09	1.03	3.09	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	46.92	101.87	4.27	4.52	1.76	2.51	1.00	0.25	0.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	138.18	104.77	8.29	7.08	2.27	3.21	0.94	0.67	0.40
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	50.92	8.04	2.68	2.68	0.89	0.89	0.89	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	71.00	13.76	9.36	10.46	4.40	4.95	1.10	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	101.51	26.10	12.76	4.64	4.06	2.32	1.16	0.58	1.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	105.58	21.58	9.62	6.50	0.78	0.65	0.65	0.13	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	93.25	14.50	7.55	3.67	3.67	2.18	1.19	0.70	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	80.09	15.50	10.48	5.80	0.33	0.78	0.11	0.45	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	198.10	31.26	14.51	7.07	3.97	2.48	0.99	0.50	0.62
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	103.14	20.28	9.21	3.85	4.55	2.91	1.40	1.05	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	91.30	17.57	8.09	4.62	3.70	3.00	1.62	1.62	0.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	113.91	14.24	7.67	5.89	1.51	1.10	1.10	0.00	0.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	102.11	15.28	7.71	4.54	5.60	4.08	0.76	2.87	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	70.42	12.36	6.63	3.23	0.18	0.18	0.54	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	119.93	14.49	7.75	4.73	2.30	1.29	0.86	0.29	0.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	99.91	16.96	6.87	4.29	2.47	1.82	0.75	0.86	0.32
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	97.14	14.60	7.52	5.53	1.11	1.33	0.66	0.44	0.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	94.82	14.53	6.88	7.07	1.15	0.96	0.76	0.00	0.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	103.60	18.07	8.48	3.07	1.68	1.49	0.75	0.47	0.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	77.61	20.11	10.15	4.32	1.32	0.75	0.56	0.56	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	115.85	16.72	7.83	8.76	1.59	0.66	0.27	0.13	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	109.22	21.61	8.27	5.55	4.58	2.14	0.68	1.17	1.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	100.06	23.68	7.45	3.44	3.06	0.95	0.95	0.38	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	119.18	17.62	7.58	5.02	0.96	0.53	0.85	0.21	0.32
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	86.05	19.06	7.01	6.45	6.73	3.36	1.12	0.84	1.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	97.41	21.53	8.72	3.76	4.10	1.88	1.20	0.68	1.03
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	94.45	13.31	5.11	5.29	0.91	0.36	0.55	0.18	0.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	102.03	20.11	8.22	4.66	3.80	2.21	0.86	1.35	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	115.78	17.46	10.07	4.70	2.28	1.61	1.07	1.07	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	107.79	16.04	6.60	6.60	3.54	0.94	0.71	0.00	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	98.21	25.00	8.33	4.37	4.37	1.79	0.20	0.60	0.79
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	97.98	18.94	7.02	2.57	1.64	1.64	1.64	0.70	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	117.57	15.97	6.01	9.54	1.87	1.04	0.83	0.00	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	83.40	19.91	7.74	4.65	3.76	1.99	1.33	1.11	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	99.43	22.35	9.19	5.64	1.67	1.04	0.84	0.42	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	138.76	22.34	10.63	7.67	2.29	1.21	0.81	0.13	0.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	101.50	20.27	6.47	4.09	2.04	0.68	0.85	0.00	0.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	88.49	17.54	7.90	3.47	2.89	1.16	0.96	0.58	0.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	136.35	19.26	6.19	10.66	3.61	1.55	1.38	0.52	0.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	92.86	17.83	7.54	3.70	2.06	1.10	0.69	0.55	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	94.40	16.09	10.01	4.27	4.10	3.94	1.64	0.82	0.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	105.33	8.35	7.16	5.79	1.19	1.02	0.17	0.17	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	142.04	21.90	10.21	3.85	2.07	2.52	0.74	0.44	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	102.62	17.33	10.93	3.20	0.53	1.07	0.27	0.53	0.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	103.70	11.75	8.30	3.32	1.52	1.38	0.28	0.00	0.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	106.19	15.24	11.43	4.52	1.43	0.95	1.43	0.24	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	145.51	22.57	9.27	4.43	1.61	2.02	0.81	0.81	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	130.24	13.66	7.16	4.61	1.13	1.32	0.94	0.09	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	104.81	21.66	13.63	3.49	3.49	2.79	0.70	0.70	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	104.57	19.64	7.25	3.93	0.60	1.51	0.30	0.60	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	104.40	15.05	8.08	4.90	1.10	0.24	1.47	0.24	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	89.81	24.89	9.75	6.40	0.87	1.31	0.58	0.29	0.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	114.99	18.25	6.69	4.26	1.22	1.22	1.83	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	94.64	10.85	6.93	5.43	1.51	1.21	0.90	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	102.69	21.49	8.60	3.39	1.36	2.71	0.90	0.00	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	114.12	23.66	9.88	3.89	3.00	0.90	0.90	0.30	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	104.02	22.20	8.50	4.25	1.18	0.47	0.83	0.12	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	84.95	19.00	7.68	1.71	1.07	0.21	1.07	1.71	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	87.14	20.43	7.81	1.20	0.00	0.00	1.20	0.00	0.00
Schwann Cells, donor1	11498-119F4	30.09	4.14	4.14	0.75	0.94	0.56	0.19	0.00	0.19
Schwann Cells, donor2	11578-120F3	51.04	0.00	6.80	0.00	0.00	0.00	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	29.14	5.26	4.82	1.10	1.53	0.88	0.44	0.00	0.00
Sebocyte, donor1	11220-116B5	129.27	64.64	8.76	7.67	1.10	1.10	1.10	0.00	0.00
Sebocyte, donor2	11301-117B5	86.86	51.93	5.97	3.68	1.84	2.30	0.92	2.30	3.22
Sebocyte, donor3	11378-118B1	32.77	30.09	2.27	2.06	0.21	0.62	0.21	0.00	0.00
Sertoli Cells, donor1	11255-116F4	66.26	61.29	3.31	1.66	4.97	0.00	0.00	0.00	0.00
Sertoli Cells, donor2	11333-117F1	8.47	14.12	0.00	0.00	0.00	2.82	0.00	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	26.31	16.80	2.20	0.97	0.62	0.44	0.18	0.09	0.00
Skeletal Muscle Cells, donor2	11358-117H8	5.78	4.34	0.72	0.00	0.00	0.00	0.72	0.00	0.00
Skeletal Muscle Cells, donor3	11430-118G8	77.75	16.72	5.85	2.51	0.84	0.84	0.00	0.00	0.00
Skeletal Muscle Cells, donor4	11451-119A2	27.81	2.83	2.83	1.10	0.16	0.47	0.16	0.00	0.00
Skeletal Muscle Cells, donor5	11455-119A6	26.90	2.53	1.64	1.34	0.30	0.15	0.15	0.00	0.00
Skeletal Muscle Cells, donor6	11459-119B1	48.48	3.69	3.85	1.69	0.31	0.62	0.31	0.00	0.15
Skeletal Muscle Satellite Cells, donor1	11240-116D7	11.97	2.39	2.39	0.38	0.13	0.63	0.25	0.13	0.00
Skeletal Muscle Satellite Cells, donor2	11321-117D7	20.40	2.28	1.85	0.43	0.29	0.43	0.00	0.00	0.00
Skeletal Muscle Satellite Cells, donor3	11397-118D2	37.90	3.27	4.66	1.49	0.69	0.40	0.50	0.10	0.30
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	13.14	11.37	1.52	0.76	0.25	0.25	0.00	0.08	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	43.43	15.20	2.90	1.45	0.00	2.17	0.00	0.00	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	10.32	6.19	0.69	0.83	0.69	0.14	0.28	0.00	0.14
Skin - palm, donor1	10286-104F7	72.52	48.35	2.69	2.69	2.69	2.69	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	36.76	16.87	2.31	2.45	0.29	0.72	0.58	0.29	0.00
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	64.61	38.44	6.54	16.36	0.00	0.00	1.64	0.00	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	28.69	10.26	2.86	1.56	0.65	0.78	0.78	0.00	0.26
Small Airway Epithelial Cells, donor1	11256-116F5	42.40	50.04	3.48	2.50	1.53	0.97	0.70	0.70	0.42
Small Airway Epithelial Cells, donor2	11334-117F2	54.86	40.51	4.22	3.38	2.25	0.84	0.42	0.28	0.14
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	105.30	65.13	6.55	10.36	0.21	0.63	0.00	0.00	0.00
Small Airway Epithelial Cells, donor3	11406-118E2	49.39	46.99	2.85	2.62	1.12	1.05	0.60	0.15	0.45
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	9.87	2.16	0.62	0.31	0.00	0.62	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	17.34	4.67	0.22	1.56	0.00	0.44	0.22	0.00	0.22
Smooth Muscle Cells - Aortic, donor0	11210-116A4	14.70	3.53	1.76	0.59	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	19.67	10.83	1.99	0.66	0.44	0.22	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor2	11360-117I1	16.93	7.09	2.36	0.79	0.79	0.39	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	6.95	0.77	1.55	0.77	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	8.01	7.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	8.78	3.99	0.67	0.13	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	7.76	2.44	0.66	0.00	0.00	0.00	0.00	0.22	0.00
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	6.79	2.56	0.77	0.26	0.00	0.13	0.13	0.00	0.00
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	18.88	3.91	1.95	1.63	0.33	0.00	0.33	0.33	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	43.71	27.76	3.25	0.89	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	36.30	21.50	2.14	2.14	0.28	0.28	0.28	0.43	0.43
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	28.79	11.55	1.95	1.46	0.33	0.33	0.16	0.33	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	21.92	14.92	2.44	0.61	0.61	0.61	0.30	0.30	0.61
Smooth Muscle Cells - Carotid, donor1	11285-116I7	8.59	1.77	1.77	0.25	0.25	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor2	11362-117I3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	17.64	2.86	0.48	0.95	0.95	0.48	0.48	0.00	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	15.34	5.46	1.77	0.29	0.29	0.44	0.00	0.00	0.15
Smooth Muscle Cells - Colonic, donor2	11320-117D6	17.65	1.72	2.37	1.08	0.22	0.22	0.65	0.00	0.22
Smooth Muscle Cells - Colonic, donor3	11396-118D1	24.67	1.68	1.99	0.84	0.52	0.21	0.00	0.21	0.10
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	20.42	6.03	2.01	0.77	0.00	0.15	0.00	0.00	0.15
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	5.39	10.78	2.16	1.08	0.00	1.08	0.00	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	15.54	2.09	1.79	0.30	0.30	0.00	0.00	0.30	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	30.73	2.05	1.71	1.37	0.34	0.00	0.00	0.34	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	17.12	4.55	1.57	0.24	0.55	0.16	0.08	0.00	0.16
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	6.04	19.93	0.91	0.50	0.50	0.10	0.40	0.20	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	25.94	14.56	0.46	1.82	0.23	0.46	0.46	0.00	0.23
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	11.47	3.62	1.81	0.00	0.00	0.00	0.00	0.00	0.60
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	72.59	5.83	10.86	2.12	1.06	0.26	0.26	0.00	0.53
Smooth Muscle Cells - Prostate, donor1	11257-116F6	50.07	20.51	4.53	3.06	0.53	0.40	0.27	0.13	0.27
Smooth Muscle Cells - Prostate, donor2	11335-117F3	24.67	11.77	2.00	2.25	0.75	0.25	0.50	0.50	0.00
Smooth Muscle Cells - Prostate, donor3	11465-119B7	8.62	7.36	1.01	0.51	0.00	0.25	0.25	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	36.64	29.25	3.77	0.90	0.45	0.30	0.15	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	11.25	3.75	0.75	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	15.51	6.46	2.58	0.00	1.29	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	9.77	0.93	1.86	0.47	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	8.58	2.52	1.01	0.50	0.00	0.50	0.50	0.50	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	7.21	5.01	0.31	0.31	0.94	0.00	0.31	0.00	0.00
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	12.09	5.31	0.88	0.88	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	82.06	9.50	7.41	2.50	0.08	0.08	0.00	0.00	0.08
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	14.01	7.94	1.40	0.47	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	24.18	17.27	2.45	1.01	0.00	0.14	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	43.09	24.99	3.82	2.04	0.25	0.25	0.25	0.51	0.25
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	42.12	11.47	2.07	2.44	0.94	0.56	0.56	0.00	0.00
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	52.82	12.72	6.43	2.24	0.28	0.28	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	38.54	19.44	2.43	1.01	0.34	0.34	0.17	0.17	0.00
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	5.71	1.90	0.95	0.48	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	25.44	19.33	1.96	1.22	0.00	0.24	0.00	0.00	0.00
Smooth Muscle Cells - Uterine, donor1	11258-116F7	44.63	74.02	1.10	4.86	1.33	1.10	0.44	0.00	0.44
Smooth Muscle Cells - Uterine, donor3	11466-119B8	25.75	6.14	2.34	0.88	0.00	0.29	0.29	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	4.66	3.50	0.19	0.39	0.00	0.00	0.00	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	7.67	7.40	1.06	0.79	0.26	0.26	0.26	0.26	0.53
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	5.21	3.35	0.00	0.37	0.74	0.74	0.00	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	5.39	13.65	0.72	1.08	1.44	0.36	0.36	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	8.23	6.81	0.85	1.14	0.57	0.00	0.00	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	54.35	17.72	3.94	7.88	2.76	1.97	0.00	0.00	0.79
Smooth muscle cells - airway, control, donor1	11966-126D4	4.83	5.59	0.51	0.51	0.00	0.00	0.25	0.51	0.00
Smooth muscle cells - airway, control, donor2	11967-126D5	5.59	5.99	1.20	0.00	0.80	0.00	0.00	0.00	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	5.02	6.69	0.00	0.42	0.00	0.42	0.00	0.42	0.42
Smooth muscle cells - airway, control, donor4	11969-126D7	10.54	6.88	0.00	1.83	0.46	0.00	0.00	0.00	0.00
Synoviocyte, donor1	11291-117A4	14.81	23.23	1.51	0.50	1.51	0.50	0.17	0.17	0.00
Synoviocyte, donor2	11368-117I9	12.07	18.77	0.50	0.50	1.01	0.34	0.00	0.17	0.17
Synoviocyte, donor3	11440-118H9	8.71	16.31	0.67	0.00	0.45	0.22	0.22	0.22	0.22
Trabecular Meshwork Cells, donor1	11532-120A2	57.17	5.00	5.72	2.86	0.00	0.00	0.36	0.00	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	19.82	0.00	1.98	0.00	3.96	1.98	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	21.07	3.24	2.08	0.46	0.46	0.23	0.69	0.00	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	59.86	30.61	5.30	2.65	0.57	0.72	0.36	0.29	0.43
Tracheal Epithelial Cells, donor2	11369-118A1	51.03	32.08	1.93	3.48	1.16	0.39	0.39	0.00	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	51.54	14.89	2.29	3.44	0.57	0.00	1.15	0.00	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	151.32	95.22	5.54	8.98	2.09	1.97	1.35	0.98	0.25
Urethra, donor2	10319-105A4	46.76	35.97	1.80	0.00	0.00	1.80	1.80	1.80	0.00
Urothelial Cells, donor1	11520-119H8	47.29	28.16	2.66	4.25	0.53	0.53	0.53	0.00	0.00
Urothelial Cells, donor2	11600-120H7	44.46	25.64	1.20	2.40	0.00	1.20	0.00	0.00	0.00
Urothelial Cells, donor3	11681-122H7	39.65	30.94	0.92	2.29	1.38	0.92	0.00	0.00	0.00
Urothelial cells, donor0	11216-116B1	58.62	35.44	2.90	2.45	0.67	2.23	0.67	0.45	0.22
Whole blood (ribopure), donor090309, donation1	12179-129A1	90.76	24.02	5.34	3.56	0.89	0.00	0.00	0.89	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	100.07	22.87	10.01	1.43	0.00	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	56.13	20.54	2.74	0.00	2.74	3.42	0.68	0.00	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	57.50	23.41	3.79	1.72	2.07	1.72	0.00	0.69	0.34
Whole blood (ribopure), donor090325, donation2	12177-128I8	47.64	19.17	6.97	4.07	1.16	1.16	0.58	0.00	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	77.05	32.28	5.21	10.41	3.12	0.00	1.04	0.00	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	98.20	36.71	7.34	10.10	0.00	1.84	1.84	0.00	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	60.25	20.08	4.56	2.74	2.74	0.00	0.91	0.00	0.00
Wilms' tumor cell line:G-401	10809-111A8	76.11	12.83	5.92	5.80	0.49	0.74	0.62	0.37	0.49
Wilms' tumor cell line:HFWT	10597-108E3	7.92	0.88	2.64	0.00	0.00	0.00	0.00	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	198.87	179.60	15.36	18.43	8.66	7.26	3.63	3.91	2.23
achilles tendon, donor2	10292-104G4	10.33	20.67	4.13	2.07	2.07	0.00	2.07	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	64.50	4.84	4.59	4.08	2.29	1.02	0.51	0.51	0.00
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	110.75	0.46	13.70	4.88	1.16	1.63	0.46	0.00	0.23
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	107.31	8.67	16.38	4.04	1.19	0.71	0.59	0.36	0.00
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	107.21	3.27	13.88	3.81	3.54	1.63	0.82	0.82	0.27
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	92.48	3.09	8.15	1.97	5.90	4.22	0.56	0.84	0.84
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	29.18	1.48	5.08	0.85	0.21	0.00	0.21	0.00	0.00
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	21.50	2.72	4.63	0.82	0.27	0.00	0.54	0.54	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	45.39	0.44	7.05	0.88	0.88	0.00	0.00	0.00	0.44
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	17.97	0.00	1.23	1.23	0.00	0.41	0.41	0.00	0.41
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	30.29	1.55	7.38	2.72	0.78	0.00	0.39	0.00	0.00
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	55.20	0.00	8.28	1.84	1.10	0.92	0.18	0.92	0.37
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	15.60	0.00	3.90	3.90	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	17.43	0.46	4.65	0.70	1.16	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	90.87	1.29	13.98	1.81	4.14	1.81	1.29	1.04	0.26
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	75.11	2.34	11.69	2.05	4.38	4.38	0.58	2.34	0.00
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	58.09	1.86	5.11	2.32	0.93	0.46	0.46	0.93	0.46
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	41.54	1.65	6.58	3.29	0.82	0.00	0.41	0.00	0.82
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	52.49	0.92	10.13	1.84	0.31	0.61	0.31	0.61	0.31
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	102.84	7.25	11.52	2.99	1.71	1.71	0.43	0.43	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	112.22	8.19	14.25	2.73	1.21	0.00	0.00	0.00	0.30
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	100.13	5.54	12.52	2.65	1.20	0.48	0.24	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	36.53	0.22	5.79	2.23	0.45	0.45	0.89	0.00	0.22
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	66.71	13.68	4.34	5.67	1.67	1.67	0.33	0.67	0.33
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	40.88	7.43	5.57	0.00	0.00	1.86	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	18.83	0.38	1.51	0.38	0.38	0.00	0.38	0.00	0.00
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	5.23	0.00	1.74	0.44	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	13.12	0.00	5.62	0.00	0.00	0.00	0.00	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	165.56	58.40	8.95	12.48	1.41	3.06	1.18	0.47	0.71
adipose tissue, adult, pool1	10010-101C1	18.30	8.22	1.71	0.47	0.47	0.31	0.16	0.00	0.00
adipose, donor1	10184-103D4	51.60	4.69	7.04	0.59	1.17	0.00	0.59	1.76	0.00
adipose, donor2	10185-103D5	16.22	3.24	2.03	0.41	0.00	0.00	0.00	0.00	0.00
adipose, donor3	10186-103D6	37.03	12.25	5.72	1.36	1.36	0.82	0.00	0.27	0.00
adipose, donor4	10187-103D7	72.81	16.47	10.40	5.20	4.33	3.47	0.00	0.00	0.87
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	54.29	2.21	8.68	0.79	0.16	1.10	0.00	0.00	0.00
adrenal gland, adult, pool1	10081-102A9	61.84	80.03	0.00	3.64	0.00	14.55	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	170.36	41.36	23.88	5.20	2.80	1.47	1.33	0.40	0.27
alveolar cell carcinoma cell line:SW 1573	10708-109H6	77.18	25.37	6.07	2.50	2.86	2.14	0.71	0.71	1.79
amniotic membrane cells, donor1	12235-129G3	553.42	702.97	16.69	24.34	11.59	7.65	9.51	4.17	3.71
amniotic membrane cells, donor2	12236-129G4	262.03	104.47	8.11	8.45	3.72	1.35	2.70	1.01	1.01
amniotic membrane cells, donor3	12237-129G5	554.44	616.90	18.56	22.39	17.09	9.13	8.84	2.06	3.24
amygdala - adult, donor10196	10167-103B5	39.13	42.69	3.56	3.56	2.37	1.19	0.00	1.19	0.00
amygdala, adult, donor10252	10151-102I7	71.17	100.17	6.08	1.42	2.64	1.82	1.22	0.81	1.01
amygdala, newborn, donor10223	10360-105E9	8.71	20.01	0.65	0.97	0.00	0.00	0.32	0.00	0.32
anaplastic carcinoma cell line:8305C	10428-106D5	31.07	15.92	2.16	1.02	0.76	0.25	0.13	0.00	0.25
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	87.15	3.53	7.50	3.31	0.88	0.88	0.44	0.44	0.44
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	125.93	43.76	10.36	18.04	0.67	1.34	0.67	0.33	0.00
aorta, adult, pool1	10052-101G7	44.72	25.89	2.35	1.96	2.75	1.37	0.00	0.39	0.00
appendix, adult	10189-103D9	116.05	50.07	8.15	4.27	4.27	0.78	0.78	1.94	1.16
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	76.35	17.20	6.53	3.44	2.41	0.69	0.34	0.00	0.00
artery, adult	10190-103E1	12.23	9.51	0.00	0.00	2.72	1.36	0.00	0.00	0.00
astrocytoma cell line:TM-31	10425-106D2	205.71	192.53	10.72	16.08	3.04	3.19	1.88	1.59	1.01
b cell line:RPMI1788	10427-106D4	108.25	42.53	9.07	4.91	1.49	1.04	0.59	0.30	0.59
basal cell carcinoma cell line:TE 354.T	10702-109G9	24.42	8.60	2.22	0.83	0.28	0.00	0.83	0.28	0.00
bile duct carcinoma cell line:HuCCT1	10432-106D9	159.17	142.50	4.86	14.49	1.79	2.18	0.69	0.30	0.79
bile duct carcinoma cell line:TFK-1	10496-107C1	110.30	65.78	4.85	7.36	1.84	2.51	0.50	1.17	0.33
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	31.32	0.56	2.24	1.68	0.56	0.00	0.56	0.00	0.00
bladder, adult, pool1	10011-101C2	66.16	54.43	5.76	2.61	1.20	1.30	0.33	0.65	0.22
blood, adult, pool1	10053-101G8	55.37	31.00	4.43	2.21	2.21	0.00	0.00	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	11.13	14.56	0.86	0.86	0.00	0.86	0.86	0.00	0.00
bone marrow, adult	10192-103E3	25.64	31.72	2.70	0.67	0.67	1.35	0.67	2.70	0.00
brain, adult, donor1	10084-102B3	15.38	50.23	0.00	2.05	1.03	3.08	1.03	1.03	1.03
brain, adult, pool1	10012-101C3	20.82	41.76	2.34	0.78	0.67	0.56	0.45	0.22	0.00
brain, fetal, pool1	10085-102B4	21.37	50.76	2.67	0.00	2.67	0.00	2.67	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	59.80	34.36	4.96	6.61	3.30	2.97	0.99	0.66	0.33
breast carcinoma cell line:MDA-MB-453	10419-106C5	166.89	51.68	8.36	13.61	1.00	1.12	0.50	0.37	0.00
breast, adult, donor1	10080-102A8	19.57	5.05	1.89	0.00	0.63	0.00	1.26	0.00	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	103.15	51.20	13.34	3.94	4.32	3.05	1.52	0.64	0.76
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	137.29	142.24	10.20	10.82	5.26	7.11	0.93	1.86	1.55
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	46.50	5.06	8.75	2.30	1.84	0.92	0.46	0.92	0.69
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	68.03	30.26	5.33	4.12	2.18	1.45	1.21	0.73	1.21
carcinoid cell line:NCI-H1770	10703-109H1	19.75	3.29	5.17	0.47	0.00	0.00	0.00	0.00	0.00
carcinoid cell line:NCI-H727	10735-110B6	111.02	35.55	6.02	6.02	0.33	0.55	0.33	0.44	0.11
carcinoid cell line:SK-PN-DW	10719-109I8	51.97	8.56	5.39	0.63	0.32	1.27	0.32	0.00	0.63
carcinosarcoma cell line:JHUCS-1	10642-109A3	67.08	7.19	9.05	1.86	2.93	2.66	1.06	0.80	0.00
caudate nucleus - adult, donor10196	10177-103C6	57.57	69.08	3.45	6.91	1.15	0.00	2.30	0.00	0.00
caudate nucleus, adult, donor10252	10164-103B2	45.18	61.41	6.02	1.51	2.18	3.01	1.00	0.17	0.67
caudate nucleus, adult, donor10258	10379-105H1	22.92	40.50	1.53	3.06	0.76	0.76	0.00	0.00	0.00
caudate nucleus, newborn, donor10223	10354-105E3	10.99	34.79	1.83	1.10	1.46	0.73	0.00	0.37	0.37
cerebellum - adult, donor10196	10173-103C2	17.48	2.91	0.00	0.00	0.00	0.00	0.00	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	13.02	17.29	1.92	0.21	0.43	0.00	0.21	0.00	0.00
cerebellum, adult, pool1	10083-102B2	2.41	6.55	0.69	0.00	0.00	0.69	0.00	0.00	0.00
cerebellum, newborn, donor10223	10357-105E6	5.81	19.10	0.83	0.00	0.00	0.00	0.00	0.00	0.00
cerebral meninges, adult	10188-103D8	24.46	40.59	2.27	0.76	0.76	0.25	1.26	1.01	0.76
cerebrospinal fluid, donor2	10294-104G6	13.89	19.00	1.46	1.46	0.73	0.00	1.46	0.73	0.00
cervical cancer cell line:D98-AH2	10552-107I3	46.59	6.33	2.01	2.59	0.43	0.29	0.00	0.00	0.00
cervical cancer cell line:ME-180	10553-107I4	66.78	100.09	2.65	3.81	1.16	0.33	0.66	0.50	0.17
cervix, adult, pool1	10013-101C4	35.70	22.89	3.57	2.52	0.42	0.52	0.73	0.21	0.10
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	43.61	5.02	2.23	1.39	0.28	0.14	0.42	0.00	0.14
chondrosarcoma cell line:SW 1353	10700-109G7	11.76	10.45	0.00	0.00	0.00	1.31	0.00	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	208.16	56.30	16.65	10.31	4.72	3.23	1.74	1.12	0.75
choriocarcinoma cell line:SCH	10785-110H2	878.38	285.73	14.17	81.07	24.64	20.45	10.35	4.56	4.68
choriocarcinoma cell line:T3M-3	10618-108G6	235.99	77.56	13.76	18.03	1.90	2.61	1.42	1.19	0.24
chorionic membrane cells, donor1	12238-129G6	281.22	357.00	6.84	9.12	5.98	7.41	5.41	1.99	1.42
chorionic membrane cells, donor2	12239-129G7	113.05	43.15	4.28	3.88	1.69	0.60	0.70	0.60	0.40
chorionic membrane cells, donor3	12240-129G8	274.74	246.17	9.34	14.29	7.14	12.09	7.14	4.40	2.75
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	62.61	5.05	9.09	6.06	2.02	3.03	0.00	0.00	1.01
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	45.91	0.58	4.99	1.73	0.96	0.19	0.58	0.19	0.00
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	90.18	7.81	7.39	2.96	0.21	0.42	0.00	0.00	0.21
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	69.59	1.80	8.47	3.34	0.26	1.03	0.51	0.00	0.77
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	85.87	4.84	9.92	2.66	1.45	1.21	0.48	0.00	0.24
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	89.38	6.31	8.76	6.11	1.02	0.41	0.41	0.20	0.00
chronic myelogenous leukemia cell line:K562	10454-106G4	36.81	2.65	5.01	1.47	1.18	0.29	0.00	0.29	0.00
chronic myelogenous leukemia cell line:KU812	10409-106B4	108.42	11.21	9.38	2.61	0.52	0.26	0.78	0.00	0.00
clear cell carcinoma cell line:JHOC-5	10638-108I8	120.01	41.60	11.20	6.40	4.11	5.03	3.43	2.06	1.37
clear cell carcinoma cell line:TEN	10636-108I6	215.49	248.81	9.20	18.39	5.73	3.30	3.30	0.69	1.56
colon carcinoma cell line:CACO-2	10513-107D9	157.05	41.18	7.50	5.86	2.01	0.55	0.73	0.18	0.18
colon carcinoma cell line:COLO-320	10420-106C6	60.43	5.32	7.22	1.14	0.76	0.38	0.00	0.00	0.00
colon, adult, donor1	10082-102B1	58.31	21.42	7.14	4.76	1.19	2.38	1.19	1.19	0.00
colon, adult, pool1	10014-101C5	81.08	135.48	4.47	5.05	1.53	1.18	0.71	0.12	0.71
colon, fetal, donor1	10070-101I7	62.42	58.09	1.24	2.47	3.71	1.85	0.62	1.24	1.24
common myeloid progenitor CMP, donor1	12130-128D6	137.51	4.58	18.33	9.17	0.00	0.00	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	25.04	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	45.89	33.99	9.77	5.52	0.00	0.42	1.27	0.00	0.42
cord blood derived cell line:COBL-a 24h infection	10453-106G3	61.28	14.79	9.81	4.53	0.30	0.00	0.45	0.15	0.60
cord blood derived cell line:COBL-a untreated	10449-106F8	77.42	11.70	14.67	6.06	1.83	1.27	0.42	0.56	0.28
corpus callosum, adult, pool1	10042-101F6	48.32	118.74	4.42	1.88	0.22	0.77	1.22	0.11	0.11
cruciate ligament, donor2	10295-104G7	15.40	15.40	0.00	0.00	1.62	0.81	1.62	0.00	0.00
diaphragm, fetal, donor1	10069-101I6	17.66	12.84	0.80	0.00	0.00	0.80	0.00	0.00	0.00
diencephalon, adult	10193-103E4	15.84	34.08	1.20	2.88	0.48	0.48	1.44	0.24	0.48
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	284.26	44.77	18.60	19.75	22.50	15.61	6.43	4.13	3.21
ductal cell carcinoma cell line:KLM-1	10438-106E6	111.29	45.65	10.77	13.59	1.28	1.54	0.26	0.00	0.00
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	153.34	151.41	9.39	5.30	6.50	3.61	1.69	0.48	0.96
ductus deferens, adult	10196-103E7	92.19	62.29	6.48	4.49	2.99	1.50	1.50	1.50	1.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	36.01	37.45	5.76	1.44	1.44	0.00	0.00	2.88	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	54.44	38.25	5.89	9.56	3.68	5.15	3.68	0.74	2.94
dura mater, adult, donor1	10041-101F5	40.88	34.19	5.37	1.65	0.17	0.50	0.08	0.25	0.08
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	48.86	16.88	4.89	7.77	1.33	0.44	0.44	0.00	0.00
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	67.20	8.45	8.88	3.87	0.57	1.00	0.57	0.43	0.14
embryonic pancreas cell line:1B2C6	10604-108F1	15.42	4.93	0.62	0.00	0.00	0.62	0.00	0.00	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	21.49	3.94	1.51	1.51	0.00	0.00	0.00	0.30	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	16.05	6.17	0.31	1.54	0.00	0.31	0.00	0.00	0.00
embryonic pancreas cell line:2C6	10603-108E9	32.84	6.57	1.31	2.63	0.00	0.00	0.00	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	106.26	67.04	9.39	5.03	1.68	2.68	1.34	1.34	1.34
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	36.43	10.69	4.53	1.63	1.45	0.91	0.91	0.36	0.00
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	293.64	194.42	17.21	19.78	21.71	15.60	6.11	3.86	2.73
epidermoid carcinoma cell line:A431	10426-106D3	236.55	252.00	14.12	19.79	2.56	3.56	1.45	1.00	0.56
epidermoid carcinoma cell line:Ca Ski	10431-106D8	150.79	52.35	7.04	6.93	1.21	0.99	1.21	0.44	0.11
epididymis, adult	10197-103E8	73.68	36.21	6.07	3.98	1.88	1.26	1.47	0.84	0.42
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	140.15	108.40	10.82	7.45	4.61	4.08	1.95	0.53	0.89
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	31.46	1.57	1.18	1.97	0.39	0.00	0.00	0.00	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	93.70	12.97	6.42	5.37	3.15	2.88	1.05	0.66	0.13
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	63.97	9.15	3.05	2.76	2.17	0.89	0.30	0.30	0.39
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	102.62	15.57	5.49	3.14	3.36	2.58	1.01	0.45	0.56
esophagus, adult, pool1	10015-101C6	90.04	83.03	4.57	4.25	2.23	2.02	1.49	0.96	0.42
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	439.45	679.15	15.65	24.42	4.88	5.01	2.63	2.25	2.00
eye - muscle inferior rectus, donor1	10272-104E2	9.66	19.32	0.00	0.00	0.00	0.00	0.00	0.00	2.41
eye - muscle lateral, donor2	10298-104H1	8.42	12.63	0.00	0.00	0.00	0.00	0.00	0.00	0.00
eye - muscle medial, donor2	10299-104H2	4.46	16.37	1.49	0.00	0.00	0.00	1.49	0.00	0.00
eye - muscle superior, donor2	10297-104G9	16.05	14.90	1.15	2.29	0.00	1.15	0.00	0.00	1.15
eye - vitreous humor, donor1	10268-104D7	24.78	18.95	2.91	1.46	1.46	0.00	0.00	0.00	0.00
eye, fetal, donor1	10054-101G9	40.42	31.02	4.07	1.27	1.27	1.27	1.27	1.27	0.25
fibrosarcoma cell line:HT-1080	10758-110E2	50.39	35.39	4.87	2.82	1.03	0.90	0.51	0.26	0.38
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	59.83	4.04	5.46	2.85	1.42	2.37	0.47	0.00	0.24
frontal lobe, adult, pool1	10040-101F4	24.96	60.52	1.22	2.25	0.66	0.56	0.19	0.47	0.09
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	196.06	119.50	8.71	12.01	8.41	10.81	3.30	2.40	3.00
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	158.73	193.21	7.50	13.53	2.01	1.46	0.91	0.73	0.64
gall bladder, adult	10198-103E9	61.57	63.26	3.38	4.59	2.90	1.69	0.97	0.24	0.72
gamma delta positive T cells, donor1	11937-126A2	95.02	47.24	9.13	6.98	0.54	1.61	0.54	0.00	0.00
gamma delta positive T cells, donor2	11938-126A3	63.12	31.37	3.73	3.73	0.75	0.75	0.37	0.37	0.00
gastric adenocarcinoma cell line:MKN1	10614-108G2	208.05	132.86	6.97	17.32	14.36	8.45	2.53	2.96	0.42
gastric adenocarcinoma cell line:MKN45	10612-108F9	103.48	23.40	6.19	4.26	2.32	2.32	1.16	0.77	0.77
gastric cancer cell line:AZ521	10549-107H9	60.66	7.21	4.26	1.80	0.49	0.33	0.00	0.16	0.00
gastric cancer cell line:GSS	10560-108A2	118.06	9.15	16.47	3.66	0.92	0.00	0.92	0.00	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	54.37	9.60	4.11	5.25	2.06	1.83	0.46	0.46	0.00
giant cell carcinoma cell line:LU65	10487-107B1	55.19	57.37	3.21	4.02	1.84	1.84	0.57	0.57	0.46
giant cell carcinoma cell line:Lu99B	10433-106E1	62.98	34.01	5.88	1.96	0.84	0.28	0.56	0.42	0.00
glassy cell carcinoma cell line:HOKUG	10688-109F4	39.41	25.94	3.24	4.99	1.00	1.25	0.00	0.00	0.25
glioblastoma cell line:A172, tech_rep1	10444-106F3	46.23	41.69	5.49	5.91	1.06	1.37	0.42	0.53	0.11
glioblastoma cell line:A172, tech_rep2	10444-106F3	51.12	45.22	4.77	4.35	1.12	1.26	0.56	0.70	0.14
glioblastoma cell line:T98G	10485-107A8	22.96	1.99	2.87	0.66	0.44	0.44	0.00	0.22	0.11
glioma cell line:GI-1	10413-106B8	16.11	5.27	1.76	1.46	0.29	0.00	0.00	0.29	0.00
globus pallidus - adult, donor10196	10175-103C4	15.31	26.97	1.46	1.46	1.46	0.73	0.00	0.00	0.00
globus pallidus, adult, donor10252	10161-103A8	37.59	71.03	4.88	0.73	1.22	1.22	0.98	0.49	0.49
globus pallidus, adult, donor10258	10367-105F7	19.17	52.03	5.48	0.00	0.00	0.00	1.37	1.37	0.00
globus pallidus, newborn, donor10223	10364-105F4	3.73	22.38	1.07	0.53	1.60	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor1	12131-128D7	188.43	34.26	14.68	19.58	0.00	0.00	2.45	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	10.93	10.93	0.00	0.00	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	36.59	5.23	15.68	0.00	0.00	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	116.48	82.24	6.08	7.36	6.08	4.16	0.96	1.60	0.64
hIPS +CCl2, biol_rep1	14383-156B9	202.47	32.14	10.56	33.97	2.75	2.30	0.00	0.00	0.00
hIPS +CCl2, biol_rep2	14384-156C1	184.73	28.81	10.06	24.69	3.66	1.83	0.46	0.00	0.00
hIPS +CCl2, biol_rep3	14385-156C2	254.42	27.70	11.59	46.37	4.51	1.29	0.00	0.00	0.00
hIPS, biol_rep1	14380-156B6	120.73	7.19	11.50	30.18	1.44	0.00	1.44	0.00	0.00
hIPS, biol_rep2	14381-156B7	152.26	25.38	13.03	19.20	2.74	1.37	0.69	0.00	1.37
hIPS, biol_rep3	14382-156B8	43.04	25.38	2.21	4.41	1.10	1.10	0.00	0.00	0.00
hairy cell leukemia cell line:Mo	10712-109I1	46.26	17.53	5.17	1.44	2.59	2.59	0.57	0.29	0.29
heart - mitral valve, adult	10205-103F7	46.94	43.35	1.79	1.49	1.49	1.20	1.20	0.30	0.30
heart - pulmonic valve, adult	10206-103F8	44.97	50.20	2.61	1.57	3.14	0.78	0.52	0.52	0.26
heart - tricuspid valve, adult	10207-103F9	16.65	14.99	0.00	1.67	0.00	1.67	0.00	0.00	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	147.94	84.68	6.73	9.39	9.39	7.96	1.84	2.45	2.04
heart, adult, diseased, donor1	10051-101G6	131.16	123.07	5.96	4.68	11.50	16.18	4.68	3.41	1.70
heart, adult, pool1	10016-101C7	60.25	37.03	3.45	1.38	0.92	0.00	0.23	0.23	0.23
heart, fetal, pool1	10046-101G1	107.71	98.68	7.08	4.00	1.44	1.23	0.41	0.21	0.31
hepatic mesenchymal tumor cell line:LI90	10778-110G4	13.58	2.47	1.54	0.93	0.00	0.00	0.00	0.00	0.00
hepatoblastoma cell line:HuH-6	10633-108I3	53.51	30.92	2.38	0.00	1.19	3.57	1.19	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	73.92	18.01	5.30	1.55	1.44	1.33	0.22	0.22	0.33
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	71.13	26.34	5.70	2.31	2.55	1.82	0.85	0.49	0.24
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	72.76	22.53	7.38	2.22	1.72	2.12	0.51	0.40	0.20
hepatoma cell line:Li-7	10484-107A7	59.72	31.59	3.45	3.23	1.45	0.78	0.22	0.67	0.11
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	52.76	15.28	5.63	3.22	0.70	0.50	0.20	0.10	0.10
hippocampus - adult, donor10196	10169-103B7	31.23	39.75	0.95	1.89	0.00	1.89	0.00	0.00	0.00
hippocampus, adult, donor10252	10153-102I9	89.60	148.38	5.10	3.67	4.08	3.67	2.45	1.84	0.82
hippocampus, adult, donor10258	10374-105G5	18.42	17.43	2.99	1.99	1.49	0.50	0.00	0.00	0.00
hippocampus, newborn, donor10223	10363-105F3	5.64	22.56	0.35	1.06	0.00	0.35	0.00	0.70	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	129.39	29.30	11.60	12.21	5.49	4.27	0.61	3.66	1.22
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	93.27	15.32	9.43	5.89	4.52	1.77	1.57	1.18	0.39
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	85.31	14.73	4.82	8.63	2.79	2.29	1.02	0.51	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	24.25	2.82	1.13	0.56	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	27.63	1.55	5.16	1.55	3.36	2.58	0.52	1.03	0.52
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	28.85	1.14	5.31	0.00	0.38	1.52	0.00	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	27.15	13.43	6.71	1.75	1.46	0.29	0.29	0.58	0.29
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	32.10	19.17	7.32	2.15	1.29	1.29	0.22	0.65	0.43
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	35.03	17.10	4.17	5.84	0.42	1.25	0.42	0.42	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	45.23	26.99	6.16	3.55	0.24	0.24	0.24	0.00	0.24
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	51.75	31.66	5.30	3.05	1.45	1.13	0.96	1.13	0.64
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	55.88	30.97	4.71	6.73	0.67	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	96.39	24.57	9.70	5.32	3.91	2.82	0.63	1.72	1.25
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	100.72	28.50	10.81	5.90	12.77	4.42	0.98	0.98	1.47
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	65.46	23.56	7.85	9.60	3.49	4.36	2.62	0.87	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	25.20	1.34	3.25	0.38	0.57	0.57	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	32.27	5.23	2.62	0.87	0.87	0.87	0.44	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	23.49	1.50	3.00	1.50	0.00	0.50	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	16.01	4.90	3.01	1.13	0.94	1.13	0.19	0.19	0.19
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	14.55	7.73	5.00	0.45	0.00	0.91	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	16.91	4.39	2.82	1.57	0.00	0.31	0.00	0.00	0.63
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	29.23	13.39	5.55	1.80	0.82	0.65	0.00	0.16	0.33
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	28.74	11.03	5.23	1.74	0.87	0.58	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	25.11	6.88	5.68	1.20	1.20	0.30	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	86.65	17.92	7.94	5.54	3.51	2.40	0.74	0.74	0.18
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	104.70	17.40	8.27	9.13	2.00	2.28	1.14	0.57	0.29
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	131.88	19.60	10.21	11.02	2.45	2.45	1.22	1.22	0.41
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	45.77	10.21	5.28	3.87	1.06	0.00	0.35	0.35	0.35
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	31.67	8.87	1.90	3.17	1.27	0.63	0.95	0.00	0.32
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	29.35	6.36	2.12	1.82	0.61	0.00	0.30	0.30	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	26.37	16.55	5.17	2.07	0.00	0.52	0.00	0.52	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	28.56	9.30	3.32	1.33	0.00	0.00	0.66	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	27.71	15.39	3.59	2.57	0.26	0.26	0.26	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	40.14	19.17	4.09	6.14	1.53	1.02	0.77	0.51	0.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	25.75	12.87	5.30	2.27	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	31.59	16.47	3.02	4.70	1.34	0.34	1.01	0.67	0.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	121.24	20.77	10.38	11.59	2.90	2.66	0.97	0.72	1.21
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	65.96	17.38	5.79	12.03	2.23	1.34	0.00	0.45	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	95.12	16.10	8.29	11.71	1.95	0.98	0.00	1.95	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	34.53	3.97	3.06	2.14	0.00	0.00	0.31	0.00	0.31
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	143.14	16.27	13.01	26.03	0.00	3.25	3.25	0.00	6.51
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	28.79	4.30	6.62	2.98	0.66	0.33	0.33	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	34.48	12.04	5.47	1.09	1.09	1.64	0.55	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	33.66	16.65	6.88	2.17	0.72	0.72	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	30.96	15.66	4.63	2.14	0.71	0.71	1.07	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	41.77	20.29	3.58	1.19	0.00	0.00	0.00	1.19	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	65.55	42.79	11.92	6.09	0.68	1.08	0.54	0.00	0.14
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	43.10	22.36	5.39	3.77	1.62	0.81	0.54	1.35	0.54
immature langerhans cells, donor1	11904-125F5	264.42	248.93	15.01	31.24	3.87	2.91	3.15	1.21	0.97
immature langerhans cells, donor2	11905-125F6	332.70	293.09	8.71	85.55	2.38	5.54	3.17	1.58	0.79
insula, adult, pool1	10039-101F3	26.31	71.64	2.65	1.42	0.66	0.57	0.19	0.19	0.19
keratoacanthoma cell line:HKA-1	10791-110H8	29.26	22.76	0.98	1.63	0.33	0.33	0.33	0.00	0.33
kidney, adult, pool1	10017-101C8	105.83	121.15	6.81	5.71	2.60	2.80	1.00	1.00	0.70
kidney, fetal, pool1	10045-101F9	104.69	100.66	9.55	3.96	0.71	1.13	0.57	0.28	0.21
large cell lung carcinoma cell line:IA-LM	10509-107D5	47.43	20.88	3.55	2.41	0.14	0.14	0.00	0.00	0.28
large cell lung carcinoma cell line:NCI-H460	10839-111E2	79.21	51.01	2.49	3.32	1.80	1.52	0.55	0.69	0.00
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	94.14	45.14	4.77	10.83	0.73	0.92	0.92	0.00	0.37
left atrium, adult, donor1	10079-102A7	44.13	39.77	1.09	1.63	2.18	3.27	1.09	0.00	1.09
left ventricle, adult, donor1	10078-102A6	38.94	27.31	1.01	1.01	1.01	0.51	0.00	1.01	0.00
leiomyoblastoma cell line:G-402	10721-110A1	80.44	18.61	7.66	5.75	1.09	1.64	0.27	0.27	0.00
leiomyoma cell line:10964C	10569-108B2	15.45	14.37	1.80	0.72	1.08	0.72	0.36	0.36	0.00
leiomyoma cell line:15242A	10570-108B3	12.50	15.76	0.54	0.00	4.35	1.09	1.09	0.54	0.00
leiomyoma cell line:15425	10571-108B4	15.30	13.35	1.94	0.73	2.19	1.70	0.00	0.00	0.49
leiomyosarcoma cell line:Hs 5.T	10722-110A2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	51.23	10.46	2.09	4.18	0.00	0.00	0.00	0.00	1.05
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	91.85	18.54	6.02	2.72	1.42	1.53	0.47	0.47	0.47
liposarcoma cell line:KMLS-1	10782-110G8	10.15	5.00	1.41	0.94	0.31	0.16	0.16	0.16	0.00
liposarcoma cell line:SW 872	10726-110A6	43.13	2.68	2.68	2.19	0.73	0.24	0.37	0.12	0.24
liver, adult, pool1	10018-101C9	34.19	17.18	1.62	1.30	0.16	0.65	0.32	0.00	0.00
liver, fetal, pool1	10086-102B5	12.23	6.58	0.94	0.00	0.00	0.00	0.00	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	14.44	28.44	3.21	1.17	0.87	0.58	1.02	0.44	0.29
locus coeruleus, adult, donor10252	10165-103B3	22.70	37.28	1.85	0.37	1.29	2.03	0.92	0.55	0.37
locus coeruleus, adult, donor10258	10375-105G6	14.39	23.98	1.69	0.85	1.13	0.28	0.85	0.56	0.28
locus coeruleus, newborn, donor10223	10362-105F2	22.71	34.49	1.68	2.52	0.00	0.42	1.26	0.42	0.00
lung adenocarcinoma cell line:A549	10499-107C4	64.49	36.12	4.29	3.60	0.28	0.00	0.00	0.42	0.28
lung adenocarcinoma cell line:PC-14	10408-106B3	93.76	52.39	9.65	4.83	0.69	0.00	0.00	0.69	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	287.23	196.67	20.30	26.89	4.61	3.82	0.92	1.85	2.64
lung, adult, pool1	10019-101D1	113.40	87.89	9.33	5.55	3.66	1.77	0.95	0.71	0.83
lung, fetal, donor1	10068-101I5	187.23	143.85	20.83	13.41	0.57	0.57	2.57	0.00	0.29
lung, right lower lobe, adult, donor1	10075-102A3	65.98	45.82	4.58	4.12	3.67	5.50	0.46	1.83	0.46
lymph node, adult, donor1	10077-102A5	55.86	22.72	3.79	0.47	2.37	0.95	0.00	0.47	0.95
lymphangiectasia cell line:DS-1	10727-110A7	133.26	36.82	7.23	4.82	2.85	1.10	0.44	0.66	0.66
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	208.88	65.50	20.53	13.58	2.72	2.11	0.91	1.36	0.60
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	101.09	59.46	8.49	7.65	0.85	0.00	0.00	0.00	0.85
mature adipocyte, donor1	12231-129F8	3.55	3.11	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mature adipocyte, donor2	12232-129F9	6.23	8.72	1.25	0.42	0.00	0.00	0.21	0.21	0.00
mature adipocyte, donor3	12233-129G1	7.35	7.82	1.19	0.00	0.24	0.00	0.00	0.00	0.24
mature adipocyte, donor4	12234-129G2	7.11	6.58	1.58	0.53	0.00	0.00	0.00	0.00	0.00
maxillary sinus tumor cell line:HSQ-89	10414-106B9	117.70	13.82	12.39	8.34	0.48	0.48	0.00	0.24	0.00
medial frontal gyrus - adult, donor10196	10170-103B8	30.46	27.07	3.38	2.26	0.00	0.00	0.00	2.26	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	43.77	72.28	4.23	1.47	1.66	1.66	1.29	0.18	0.37
medial frontal gyrus, adult, donor10258	10368-105F8	14.93	20.01	0.95	0.32	1.59	0.64	0.64	0.00	0.64
medial frontal gyrus, newborn, donor10223	10352-105E1	7.68	26.44	0.85	0.43	0.85	0.43	0.00	0.85	0.43
medial temporal gyrus - adult, donor10196	10183-103D3	26.16	41.18	1.69	1.52	7.59	4.39	1.52	2.19	0.68
medial temporal gyrus, adult, donor10252	10156-103A3	53.69	84.89	2.97	2.76	2.55	2.55	0.85	0.21	0.00
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	13.48	17.34	1.93	11.56	0.00	0.00	0.00	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	43.06	157.89	14.35	14.35	0.00	14.35	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	3.59	26.92	0.36	0.00	1.08	0.00	0.00	0.00	0.36
medulla oblongata - adult, donor10196	10174-103C3	53.22	73.98	4.54	3.89	2.60	0.00	0.65	0.65	0.00
medulla oblongata, adult, donor10252	10155-103A2	55.26	92.73	4.95	1.70	2.17	2.01	1.39	0.62	0.62
medulla oblongata, adult, pool1	10038-101F2	33.79	87.83	3.51	1.06	0.57	0.57	0.98	0.33	0.08
medulla oblongata, newborn, donor10223	10361-105F1	22.22	38.88	3.47	2.78	0.35	1.74	0.69	0.69	0.35
medulloblastoma cell line:D283 Med	10838-111E1	90.56	18.60	7.09	5.98	0.66	2.21	0.66	0.89	0.44
medulloblastoma cell line:ONS-76	10759-110E3	65.54	7.95	6.48	2.69	0.86	0.12	0.12	0.00	0.24
melanoma cell line:COLO 679	10514-107E1	49.16	25.44	3.16	1.72	0.29	0.14	0.29	0.14	0.00
melanoma cell line:G-361	10465-106H6	10.04	2.71	0.54	0.00	0.00	0.27	0.00	0.00	0.00
meningioma cell line:HKBMM	10691-109F7	46.31	29.49	2.35	0.90	2.71	1.81	0.72	0.72	0.90
merkel cell carcinoma cell line:MKL-1	10843-111E6	77.54	13.22	9.69	5.29	4.41	1.76	0.88	0.00	0.88
merkel cell carcinoma cell line:MS-1	10844-111E7	139.46	36.55	9.85	5.96	4.15	1.30	2.33	1.81	1.30
mesenchymal precursor cell - adipose, donor1	11747-123G1	15.80	1.38	0.61	0.46	0.15	0.00	0.31	0.15	0.15
mesenchymal precursor cell - adipose, donor2	11748-123G2	7.63	2.00	0.91	0.36	0.00	0.00	0.55	0.00	0.00
mesenchymal precursor cell - adipose, donor3	11749-123G3	18.22	1.24	1.66	0.41	0.00	0.00	0.00	0.00	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	13.20	7.87	1.12	0.28	0.14	0.00	0.00	0.00	0.00
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	11.17	8.09	1.73	0.39	0.00	0.39	0.19	0.00	0.19
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	4.16	5.55	0.00	1.39	0.69	0.00	0.00	0.00	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	15.62	3.43	0.51	0.69	0.17	0.00	0.00	0.00	0.00
mesenchymal precursor cell - cardiac, donor2	11753-123G7	11.73	5.87	1.15	0.23	0.58	0.35	0.12	0.00	0.00
mesenchymal precursor cell - cardiac, donor3	11754-123G8	17.91	2.79	1.46	0.27	0.13	0.00	0.00	0.00	0.00
mesenchymal precursor cell - cardiac, donor4	11755-123G9	19.04	2.97	0.81	0.68	0.41	0.00	0.00	0.27	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	72.84	49.65	2.70	3.13	2.28	1.56	0.28	0.28	0.43
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	9.88	3.62	0.66	0.99	0.00	0.00	0.00	0.00	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	79.70	49.12	2.77	4.01	1.80	0.83	0.28	0.42	0.28
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	26.53	7.33	2.44	1.75	1.40	0.35	1.05	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	39.00	25.72	1.22	1.43	1.02	0.41	0.61	0.00	0.20
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	27.68	35.59	2.16	2.16	1.08	1.44	0.72	0.00	0.36
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	103.45	92.38	3.10	6.62	2.48	0.72	0.93	0.41	0.41
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	119.70	206.33	3.42	14.59	7.30	5.70	5.02	1.60	1.60
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	145.17	121.67	8.39	8.39	3.78	3.36	2.10	0.00	1.68
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	24.06	12.70	0.75	1.49	0.60	0.30	0.00	0.60	0.15
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	118.25	92.69	3.85	4.90	3.50	1.93	0.70	0.70	0.70
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	35.34	27.24	2.58	1.84	0.37	0.00	0.74	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	24.32	26.04	1.43	1.43	1.43	0.29	0.29	0.29	0.86
mesenchymal stem cell line:Hu5/E18	10568-108B1	48.42	29.05	5.89	3.37	2.11	0.84	0.42	1.68	0.84
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	8.68	1.83	0.91	0.46	0.46	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	7.42	2.05	1.53	1.53	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	9.95	2.62	0.00	0.26	0.26	0.79	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	6.47	1.23	1.23	0.31	0.31	0.92	0.00	0.00	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	7.06	3.53	0.47	0.47	0.24	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	6.09	2.37	0.00	0.34	0.00	0.34	0.34	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	6.29	2.75	1.18	0.39	0.39	0.39	0.39	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	5.10	3.71	0.00	0.46	0.00	0.00	0.00	0.46	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	8.08	3.46	1.73	0.58	0.87	0.29	0.00	0.00	0.29
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	9.82	2.68	1.12	0.89	0.00	0.22	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	8.65	2.64	1.20	1.20	0.48	0.24	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	8.07	5.13	0.73	0.73	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	7.72	2.01	0.34	0.67	0.34	0.00	0.34	0.00	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	6.14	1.23	0.41	0.41	0.00	0.00	0.00	0.41	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	6.87	3.87	0.43	0.43	0.00	0.43	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	10.94	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	6.50	2.27	0.65	0.00	0.00	0.32	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	8.73	7.27	0.00	0.00	0.00	0.00	1.45	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	7.46	3.20	1.07	0.53	0.00	0.00	0.53	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	5.72	6.54	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	7.00	2.33	2.72	0.78	0.39	0.00	0.39	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	6.30	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	4.97	7.95	1.99	0.99	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	14.30	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	8.89	4.15	1.78	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	10.97	6.09	1.22	0.00	2.44	0.00	1.22	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	12.03	5.07	0.63	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	5.52	4.48	0.34	0.34	0.34	0.34	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	8.60	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	11.98	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	0.00	3.44	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	2.85	0.81	0.41	0.41	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	0.79	0.79	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	0.59	0.59	0.59	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	2.49	0.62	0.31	0.00	0.00	0.31	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	2.67	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	2.37	0.00	0.00	0.00	0.00	0.00	1.18	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	2.57	2.57	0.00	0.00	0.00	0.00	0.00	0.00	2.57
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	3.44	0.69	0.00	0.00	0.00	0.00	0.00	0.69	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	5.44	1.48	0.00	0.00	0.00	0.49	0.49	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	2.24	1.12	0.00	1.12	0.00	0.00	1.12	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	6.36	0.64	0.00	0.64	0.00	0.64	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	8.06	0.81	0.00	0.40	0.40	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	2.18	0.00	0.00	0.00	2.18	2.18	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	6.34	1.27	2.53	1.27	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	6.07	0.61	0.00	0.61	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	9.04	0.00	0.00	0.00	4.52	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	1.65	2.47	0.82	0.00	0.82	0.82	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	1.59	0.20	0.40	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	0.65	0.32	0.65	0.00	0.32	0.32	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	5.09	1.02	1.02	0.00	0.00	0.00	0.00	0.00	1.02
mesodermal tumor cell line:HIRS-BM	10696-109G3	15.47	17.80	2.32	0.77	0.00	0.00	0.00	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	138.67	72.05	7.09	5.20	3.54	1.18	0.00	0.24	0.71
mesothelioma cell line:ACC-MESO-4	10494-107B8	160.55	256.23	6.02	11.58	4.87	3.94	1.62	0.93	1.16
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	98.29	98.29	4.27	12.82	8.55	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	95.56	57.75	5.75	4.11	3.19	3.19	1.85	0.82	0.51
mesothelioma cell line:Mero-25	10850-111F4	79.89	28.60	6.13	5.90	3.18	4.77	2.27	1.36	1.13
mesothelioma cell line:Mero-41	10851-111F5	68.94	30.80	4.40	6.11	3.18	1.71	1.47	0.98	0.00
mesothelioma cell line:Mero-48a	10852-111F6	240.47	245.35	10.85	25.24	11.96	9.74	3.10	2.88	1.99
mesothelioma cell line:Mero-82	10853-111F7	169.77	164.52	5.26	18.40	13.14	13.67	2.89	2.89	3.42
mesothelioma cell line:Mero-83	10854-111F8	48.51	42.90	3.23	4.77	2.89	2.55	0.85	0.34	0.68
mesothelioma cell line:Mero-84	10855-111F9	127.90	162.03	5.31	12.39	6.07	4.04	3.03	1.26	2.02
mesothelioma cell line:Mero-95	10856-111G1	82.20	85.72	6.21	13.87	3.93	1.66	1.66	0.83	1.04
mesothelioma cell line:NCI-H2052	10847-111F1	65.27	44.89	3.31	4.64	3.98	2.32	1.16	0.66	0.83
mesothelioma cell line:NCI-H226	10846-111E9	171.40	167.96	6.52	19.00	11.95	7.60	2.53	2.71	0.90
mesothelioma cell line:NCI-H2452	10848-111F2	145.20	90.19	8.54	11.96	5.81	4.27	2.90	1.88	0.68
mesothelioma cell line:NCI-H28	10845-111E8	53.69	58.78	6.11	4.33	3.05	3.56	1.53	0.25	0.76
mesothelioma cell line:No36	10857-111G2	38.49	6.20	1.63	2.94	0.65	0.98	0.98	0.00	0.65
mesothelioma cell line:ONE58	10858-111G3	78.03	39.83	3.52	10.03	4.88	3.79	2.17	0.54	0.81
migratory langerhans cells, donor1	11901-125F2	101.34	38.77	17.46	14.59	1.34	1.34	1.73	0.38	0.19
migratory langerhans cells, donor2	11902-125F3	95.62	38.34	8.91	8.55	1.22	0.12	0.98	0.98	0.24
migratory langerhans cells, donor3	11903-125F4	69.28	17.59	9.33	3.77	1.08	0.00	1.26	0.00	0.18
mixed mullerian tumor cell line:HTMMT	10689-109F5	58.11	12.08	2.94	1.96	2.94	4.57	2.94	1.31	0.33
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	50.65	8.48	2.54	0.85	1.06	1.48	0.42	0.42	0.42
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	252.47	239.34	9.44	19.12	3.23	5.53	0.46	1.15	2.53
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	70.03	24.36	6.66	3.04	0.76	1.71	0.19	0.00	0.19
myelodysplastic syndrome cell line:SKM-1	10772-110F7	52.85	1.29	6.84	1.85	0.00	0.74	0.37	0.18	0.18
myeloma cell line:PCM6	10474-106I6	59.89	49.61	7.71	1.98	0.79	0.59	0.40	0.40	1.19
myxofibrosarcoma cell line:MFH-ino	10600-108E6	73.05	46.67	3.55	3.55	1.52	3.04	0.51	0.51	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	26.28	1.18	1.96	1.37	0.20	0.20	0.00	0.20	0.00
nasal epithelial cells, donor1, tech_rep1	12226-129F3	51.14	43.57	3.12	1.00	0.67	0.22	0.45	0.11	0.11
nasal epithelial cells, donor1, tech_rep2	12226-129F3	37.29	38.17	2.06	2.28	0.37	0.15	0.29	0.07	0.15
nasal epithelial cells, donor2	12227-129F4	95.49	65.69	2.76	3.86	2.76	1.10	1.10	0.00	0.00
neuroblastoma cell line:CHP-134	10508-107D4	38.19	17.94	3.91	1.61	0.46	0.69	0.00	0.00	0.00
neuroblastoma cell line:NB-1	10539-107G8	158.46	107.39	16.09	4.68	1.68	1.87	1.50	0.19	0.75
neuroblastoma cell line:NBsusSR	10607-108F4	36.27	3.16	5.06	2.53	0.63	0.84	0.42	0.21	0.00
neuroblastoma cell line:NH-12	10555-107I6	69.51	7.45	9.32	2.80	1.30	0.75	0.56	0.19	0.37
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	31.79	14.23	5.46	0.95	1.19	1.19	0.00	0.24	0.00
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	81.88	30.25	4.43	4.43	3.80	2.38	1.27	0.16	0.48
neuroectodermal tumor cell line:TASK1	10774-110F9	36.03	4.43	3.02	0.40	1.01	0.40	0.60	0.00	0.00
neuroepithelioma cell line:SK-N-MC	10728-110A8	40.05	5.09	3.81	3.81	0.64	0.00	0.64	0.00	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	43.12	15.70	1.33	1.06	0.80	0.53	0.53	0.27	0.00
neutrophil PMN, donor1	12133-128D9	119.00	0.00	14.87	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	0.00	0.00	13.28	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	9.47	0.00	18.94	0.00	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	138.00	4.06	27.90	2.88	1.01	0.51	0.34	0.68	0.34
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	10.41	5.60	0.80	0.80	0.80	0.00	0.00	0.00	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	10.58	7.05	0.00	1.28	0.00	0.32	0.00	0.32	0.00
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	36.00	9.20	3.42	1.31	1.84	1.05	0.79	0.00	0.00
nucleus accumbens, adult, pool1	10037-101F1	35.43	77.99	2.72	2.25	0.56	0.37	0.66	0.19	0.09
occipital cortex - adult, donor10196	10172-103C1	10.30	53.57	0.00	4.12	0.00	0.00	2.06	0.00	2.06
occipital cortex, adult, donor10252	10163-103B1	43.21	70.85	4.56	1.61	2.42	3.49	0.27	0.81	0.81
occipital cortex, newborn, donor10223	10355-105E4	8.01	13.83	0.36	0.36	0.00	0.00	0.00	0.00	0.00
occipital lobe, adult, donor1	10076-102A4	20.99	37.26	2.62	0.26	0.26	0.26	1.31	0.00	0.26
occipital lobe, fetal, donor1	10073-102A1	26.18	33.47	1.72	2.15	1.29	0.86	1.29	0.00	0.43
occipital pole, adult, pool1	10036-101E9	18.29	45.81	1.73	1.50	0.24	0.63	0.55	0.00	0.00
olfactory region, adult	10195-103E6	28.85	53.88	3.06	0.38	1.72	2.87	1.34	0.96	0.38
optic nerve, donor1	10277-104E7	4.00	2.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	96.59	88.73	3.76	8.88	1.48	0.57	0.34	0.34	0.00
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	135.88	55.23	9.48	7.28	1.51	1.51	0.41	0.27	0.27
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	58.76	46.90	3.56	2.54	7.79	3.22	1.69	1.35	0.34
oral squamous cell carcinoma cell line:SAS	10544-107H4	206.99	97.14	12.47	18.94	4.85	5.66	3.12	1.73	0.92
osteoclastoma cell line:Hs 706.T	10704-109H2	27.04	21.46	2.65	0.88	0.88	0.00	0.00	0.00	0.29
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	57.93	7.47	4.67	2.80	0.00	1.87	0.93	0.00	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	28.20	30.54	2.33	1.48	0.85	0.85	0.00	0.00	0.00
ovary, adult, pool1	10020-101D2	52.06	28.39	5.94	1.31	0.44	0.61	0.26	0.17	0.09
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	46.20	6.42	2.93	2.20	1.65	0.73	0.55	0.18	0.73
pancreas, adult, donor1	10049-101G4	85.60	39.51	3.76	2.82	4.70	0.00	0.94	0.94	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	192.88	46.96	4.19	15.09	5.59	4.75	1.96	1.68	1.12
papillary adenocarcinoma cell line:8505C	10437-106E5	77.85	15.16	5.28	4.26	4.60	4.26	1.36	2.04	0.85
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	293.08	405.68	11.09	27.49	3.81	4.14	2.48	1.99	0.99
paracentral gyrus, adult, pool1	10035-101E8	21.23	56.10	1.65	1.28	0.64	0.46	0.00	0.18	0.18
parietal cortex, adult, donor10258	10373-105G4	24.22	30.09	0.73	3.67	0.73	2.94	0.00	0.00	0.00
parietal lobe - adult, donor10196	10171-103B9	23.51	27.27	0.00	0.94	0.00	0.00	0.00	0.94	0.00
parietal lobe, adult, donor10252	10157-103A4	43.61	59.57	2.85	1.71	1.71	2.28	0.57	0.00	0.86
parietal lobe, adult, pool1	10034-101E7	25.03	61.86	1.94	1.59	0.53	0.35	0.35	0.18	0.09
parietal lobe, fetal, donor1	10072-101I9	46.55	42.67	2.91	1.94	5.82	0.97	0.97	0.97	0.00
parietal lobe, newborn, donor10223	10356-105E5	5.98	15.70	0.75	1.87	0.37	0.37	0.00	0.00	0.00
parotid gland, adult	10199-103F1	49.95	14.18	1.23	0.62	2.47	1.85	1.23	0.00	0.00
penis, adult	10200-103F2	40.82	25.78	4.83	0.54	3.22	1.07	2.15	0.00	0.54
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	66.19	77.54	3.53	3.90	3.90	4.09	2.05	0.93	0.37
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	91.93	50.70	4.52	5.97	3.06	1.46	0.73	1.46	0.87
pineal gland - adult, donor10196	10179-103C8	6.45	9.68	1.29	0.65	0.65	0.00	0.00	0.65	0.00
pineal gland, adult, donor10252	10160-103A7	8.88	12.44	2.96	0.00	0.00	0.00	0.00	0.59	0.00
pineal gland, adult, donor10258	10377-105G8	5.02	3.14	0.00	0.00	0.00	0.00	0.63	0.00	0.00
pituitary gland - adult, donor10196	10180-103C9	39.46	30.35	7.08	4.05	3.04	1.01	0.00	0.00	0.00
pituitary gland, adult, donor10252	10162-103A9	56.29	63.58	8.34	1.56	1.04	0.52	0.52	0.00	0.00
pituitary gland, adult, donor10258	10378-105G9	22.13	14.47	3.40	1.70	1.70	1.70	0.85	0.85	1.70
placenta, adult, pool1	10021-101D3	277.89	201.25	12.15	15.70	3.23	2.26	1.61	1.72	1.40
plasma cell leukemia cell line:ARH-77	10840-111E3	89.39	30.33	8.61	3.97	1.06	0.53	0.66	0.13	0.53
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	42.65	7.94	3.27	0.47	0.47	0.16	0.00	0.00	0.16
pons, adult, pool1	10033-101E6	12.57	27.97	0.86	0.60	0.34	0.34	0.69	0.09	0.00
postcentral gyrus, adult, pool1	10032-101E5	15.95	50.56	2.09	0.96	0.44	0.61	0.35	0.35	0.00
promyelocytes/myelocytes PMC, donor1	12132-128D8	56.47	2.09	14.64	8.37	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	11.02	0.00	5.51	0.00	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	23.47	0.00	11.74	0.00	0.00	0.00	11.74	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	101.82	29.86	9.47	4.08	2.48	1.46	0.29	1.60	0.73
prostate cancer cell line:PC-3	10439-106E7	112.71	21.05	6.90	5.08	2.54	2.72	0.54	0.91	0.73
prostate, adult, pool1	10022-101D4	52.51	37.64	5.62	2.18	0.45	0.45	0.18	0.18	0.09
putamen, adult, donor10196	10176-103C5	42.73	73.42	3.30	1.65	2.83	3.54	0.47	0.94	0.24
putamen, adult, donor10252	10152-102I8	9.80	15.69	1.96	0.00	1.96	0.00	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	74.31	20.76	7.65	27.32	1.09	0.00	1.09	0.00	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	24.16	37.69	1.93	2.17	2.17	0.97	0.48	0.72	0.24
putamen, newborn, donor10223	10365-105F5	9.75	29.99	0.75	0.00	2.25	0.75	0.00	0.00	0.00
rectal cancer cell line:TT1TKB	10469-106I1	163.21	180.67	7.27	10.76	3.20	3.49	0.87	0.87	0.58
rectum, fetal, donor1	10067-101I4	38.95	26.43	1.39	1.39	0.00	1.39	1.39	0.00	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	36.25	30.10	5.72	1.27	1.48	0.64	0.42	0.21	0.00
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	59.23	9.94	4.56	1.66	0.83	2.90	0.00	0.41	0.41
retina, adult, pool1	10030-101E3	50.79	149.70	3.58	3.58	0.99	1.39	0.40	0.20	0.50
retinoblastoma cell line:Y79	10475-106I7	89.37	5.20	14.29	2.86	1.82	0.26	0.78	0.26	0.52
rhabdomyosarcoma cell line:KYM-1	10787-110H4	37.50	2.95	3.69	1.48	0.12	0.61	0.25	0.12	0.00
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	50.33	8.72	5.06	1.97	0.56	0.56	0.00	0.00	0.56
sacrococcigeal teratoma cell line:HTST	10695-109G2	12.88	10.61	2.27	2.27	0.00	1.52	0.00	0.00	0.00
salivary acinar cells, donor1	11771-123I7	34.48	23.79	2.27	1.46	0.49	1.13	0.16	0.49	0.00
salivary acinar cells, donor2	11772-123I8	37.59	40.07	3.17	1.24	1.24	0.41	1.10	0.28	0.28
salivary acinar cells, donor3	11773-123I9	38.40	54.29	0.00	2.65	0.66	3.31	0.00	0.00	0.66
salivary gland, adult, pool1	10093-102C3	74.35	26.88	8.01	4.58	2.29	1.14	0.00	0.00	0.57
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	22.34	17.71	3.12	1.85	0.34	0.34	0.00	0.08	0.00
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	26.21	16.57	2.23	1.88	0.24	0.47	0.35	0.24	0.24
seminal vesicle, adult	10201-103F3	76.72	66.13	3.70	3.17	5.82	3.17	4.76	3.17	2.12
serous adenocarcinoma cell line:JHOS-2	10639-108I9	140.41	117.33	5.59	8.99	6.07	5.59	4.37	1.70	0.49
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	86.56	45.04	4.53	5.79	2.01	1.01	0.75	0.75	0.50
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	119.42	76.27	11.04	10.04	9.03	2.01	1.00	1.00	1.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	183.62	189.93	8.19	13.16	9.54	7.79	3.36	2.15	2.15
signet ring carcinoma cell line:Kato III	10436-106E4	264.38	214.76	12.49	13.59	4.09	3.87	1.99	1.33	1.44
signet ring carcinoma cell line:NUGC-4	10483-107A6	108.12	99.61	10.06	8.90	1.42	1.16	0.26	0.39	0.39
skeletal muscle - soleus muscle, donor1	10282-104F3	4.97	2.84	1.42	0.71	1.42	0.00	0.00	0.71	0.00
skeletal muscle, adult, pool1	10023-101D5	17.87	7.56	1.80	0.36	0.36	0.12	0.12	0.12	0.00
skeletal muscle, fetal, donor1	10066-101I3	10.05	5.03	0.00	0.00	2.01	0.00	0.00	0.00	0.00
skin, adult, donor1	10074-102A2	61.07	13.57	6.79	0.00	6.79	6.79	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	49.24	25.88	1.89	2.52	0.00	0.63	3.16	0.63	0.00
small cell cervical cancer cell line:HCSC-1	10800-110I8	52.36	7.34	5.67	3.67	0.67	0.67	0.00	0.00	0.33
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	59.89	7.88	3.78	5.99	3.47	1.58	0.00	0.63	0.32
small cell lung carcinoma cell line:DMS 144	10841-111E4	37.97	3.28	4.63	0.77	0.39	0.39	0.58	0.39	0.19
small cell lung carcinoma cell line:LK-2	10541-107H1	114.72	20.77	12.86	3.63	1.32	0.49	0.33	0.49	0.16
small cell lung carcinoma cell line:NCI-H82	10842-111E5	75.76	3.06	14.32	1.93	0.97	1.29	0.64	0.64	0.32
small cell lung carcinoma cell line:WA-hT	10562-108A4	142.08	16.56	10.90	10.24	2.18	1.96	0.44	0.22	0.65
small intestine, adult, pool1	10024-101D6	135.33	331.22	5.97	9.44	2.75	2.99	1.19	1.79	0.84
small intestine, fetal, donor1	10064-101I1	97.54	108.84	4.42	3.19	9.09	6.14	1.47	1.47	1.47
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	15.90	5.64	3.08	1.54	0.00	2.05	0.00	0.00	0.51
smooth muscle, adult, pool1	10048-101G3	43.16	37.22	5.17	1.29	1.29	2.07	0.52	0.00	0.26
somatostatinoma cell line:QGP-1	10781-110G7	34.84	14.47	2.41	3.48	1.07	0.00	0.00	0.00	0.27
spinal cord - adult, donor10196	10181-103D1	12.62	45.19	2.29	0.23	2.75	1.61	0.23	1.15	0.69
spinal cord, adult, donor10252	10159-103A6	18.53	58.75	2.37	0.39	1.18	1.97	0.79	0.79	0.00
spinal cord, adult, donor10258	10369-105F9	17.99	67.10	4.15	3.46	2.08	1.38	0.00	0.00	0.00
spinal cord, fetal, donor1	10056-101H2	39.64	100.62	2.44	1.22	1.83	2.44	1.83	0.61	1.83
spinal cord, newborn, donor10223	10359-105E8	17.45	42.25	1.84	0.46	1.38	1.38	0.92	0.00	0.00
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	56.01	22.85	3.73	2.09	0.75	1.19	0.30	0.00	0.30
spleen, adult, pool1	10025-101D7	68.39	33.70	5.62	2.09	0.55	0.55	0.22	0.55	0.11
spleen, fetal, pool1	10044-101F8	73.50	37.50	7.71	2.86	0.48	0.48	0.24	0.48	0.08
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	73.08	12.11	10.45	4.66	1.97	1.04	0.93	0.41	0.31
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	125.51	47.47	7.78	4.37	1.71	1.71	0.19	0.38	0.76
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	173.33	66.40	8.04	13.98	9.78	14.33	4.19	3.84	2.45
squamous cell carcinoma cell line:T3M-5	10616-108G4	134.48	132.13	4.30	9.38	4.69	5.47	3.13	2.74	0.78
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	54.25	47.39	1.69	3.04	0.68	0.56	0.34	0.34	0.34
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	39.82	2.12	3.39	1.69	0.85	0.00	0.00	0.42	0.42
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	209.84	30.88	11.00	15.65	1.27	0.42	0.85	0.42	0.42
stomach, fetal, donor1	10062-101H8	176.22	96.12	1.07	9.61	1.07	0.00	0.00	0.00	0.00
submaxillary gland, adult	10202-103F4	38.74	9.68	2.85	0.57	2.28	1.14	1.14	0.57	0.57
substantia nigra - adult, donor10196	10178-103C7	54.27	54.27	0.00	0.00	54.27	54.27	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	20.36	50.26	3.32	0.42	1.87	2.08	0.83	1.45	0.21
substantia nigra, adult, donor10258	10371-105G2	23.28	32.59	0.52	1.55	0.00	2.59	1.03	0.00	0.00
substantia nigra, newborn, donor10223	10358-105E7	4.95	24.02	0.00	0.00	0.71	0.71	0.00	0.00	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	4.36	0.46	1.60	0.00	0.23	0.00	0.00	0.00	0.23
temporal lobe, adult, pool1	10031-101E4	23.06	62.22	1.86	1.86	0.76	0.68	0.76	0.08	0.17
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	39.17	47.01	6.41	2.14	2.14	2.85	1.42	0.00	0.71
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	47.03	35.16	3.96	3.52	3.96	0.88	1.76	0.44	0.00
tenocyte, donor1	11763-123H8	25.14	13.96	2.44	0.70	1.75	0.00	1.05	0.70	0.70
tenocyte, donor2	11765-123I1	13.73	15.64	0.00	0.38	0.76	0.38	0.00	0.00	0.00
tenocyte, donor3	11768-123I4	21.87	9.64	0.74	1.48	2.22	0.74	0.37	0.74	0.74
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	256.64	84.47	18.70	16.49	5.61	4.59	2.04	1.53	1.02
teratocarcinoma cell line:NCR-G1	10798-110I6	28.98	3.08	2.62	0.62	1.08	0.46	0.15	0.00	0.00
teratocarcinoma cell line:PA-1	10807-111A6	115.61	12.09	7.44	3.25	1.24	1.24	0.31	0.31	0.46
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	174.55	53.70	5.71	10.92	2.92	2.67	0.51	0.89	0.38
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	268.88	60.13	28.36	17.77	3.78	1.89	3.03	1.51	1.13
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	240.26	88.34	7.96	8.83	4.14	2.62	0.98	0.87	0.65
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	98.69	31.92	13.03	3.91	10.10	8.47	1.30	3.26	1.63
testis, adult, pool1	10026-101D8	59.05	56.05	6.01	1.83	1.07	0.64	0.86	0.43	0.43
testis, adult, pool2	10096-102C6	71.72	64.05	12.63	6.32	5.86	6.32	3.16	2.26	1.35
thalamus - adult, donor10196	10168-103B6	19.87	43.06	2.21	3.31	0.00	2.21	0.00	1.10	1.10
thalamus, adult, donor10252	10154-103A1	44.54	79.55	4.06	1.56	2.03	1.25	1.88	0.47	0.47
thalamus, adult, donor10258, tech_rep1	10370-105G1	16.94	26.17	6.16	10.78	1.54	0.00	1.54	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	12.19	33.93	1.81	1.81	0.99	0.99	1.32	0.00	0.33
thalamus, newborn, donor10223	10366-105F6	4.03	23.59	0.58	0.58	0.00	0.58	0.00	0.00	1.73
throat, adult	10209-103G2	64.66	66.66	3.50	4.49	3.25	0.25	1.50	1.75	0.00
throat, fetal, donor1	10061-101H7	59.72	32.30	4.88	2.13	1.52	2.44	0.61	0.61	0.91
thymic carcinoma cell line:Ty-82	10803-111A2	15.90	0.20	4.77	0.40	0.00	0.00	0.20	0.00	0.00
thymus, adult, pool1	10027-101D9	151.71	22.87	16.70	4.57	1.69	1.19	0.99	0.50	0.40
thymus, fetal, pool1	10043-101F7	143.91	56.84	14.03	6.65	0.62	0.73	0.52	0.83	0.31
thyroid carcinoma cell line:KHM-5M	10776-110G2	50.13	3.06	5.58	3.72	0.40	1.06	0.66	0.13	0.53
thyroid carcinoma cell line:TCO-1	10783-110G9	92.75	41.91	4.89	5.45	2.24	1.26	0.42	0.70	0.98
thyroid, adult, pool1	10028-101E1	77.92	99.56	4.85	2.61	1.68	1.12	0.93	0.28	0.47
thyroid, fetal, donor1	10060-101H6	46.93	47.99	4.75	2.90	2.37	2.90	0.79	0.79	0.79
tongue epidermis (fungiform papillae), donor1	10288-104F9	33.88	61.59	15.40	0.00	3.08	3.08	0.00	0.00	0.00
tongue, adult	10203-103F5	69.08	55.12	4.88	3.72	6.51	3.95	0.93	1.16	0.93
tongue, fetal, donor1	10059-101H5	50.44	31.53	3.94	2.76	1.58	1.97	0.79	0.00	1.18
tonsil, adult, pool1	10047-101G2	230.00	145.66	15.93	12.62	1.80	1.50	0.80	0.50	0.40
trachea, adult, pool1	10029-101E2	104.37	66.99	9.41	7.36	0.74	0.82	0.33	0.25	0.33
trachea, fetal, donor1	10058-101H4	44.62	41.93	5.00	2.69	3.85	1.54	1.54	0.00	0.38
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	57.04	19.13	4.25	2.48	3.19	1.06	0.35	1.06	0.71
transitional-cell carcinoma cell line:5637	10418-106C4	110.23	51.37	9.83	6.59	0.61	0.71	0.20	0.10	0.00
transitional-cell carcinoma cell line:JMSU1	10492-107B6	137.26	43.25	14.89	5.80	1.72	2.98	0.31	0.94	0.16
tridermal teratoma cell line:HGRT	10694-109G1	19.03	5.71	0.00	1.90	0.00	0.00	0.00	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	60.61	39.87	2.96	4.49	1.27	0.85	0.76	0.17	0.34
umbilical cord, fetal, donor1	10057-101H3	68.85	39.64	2.09	2.09	2.09	2.09	0.00	0.00	0.00
uterus, adult, pool1	10100-102D1	38.39	11.09	3.58	2.39	0.34	0.34	0.34	0.17	0.00
uterus, fetal, donor1	10055-101H1	39.93	28.67	4.10	1.02	0.00	2.56	0.00	0.51	0.51
vagina, adult	10204-103F6	36.83	14.22	2.58	0.65	0.65	0.65	0.00	0.00	0.65
vein, adult	10191-103E2	73.21	30.03	5.26	2.85	1.32	1.53	1.10	1.10	0.00
xeroderma pigentosum b cell line:XPL 17	10563-108A5	86.52	22.43	7.21	3.74	1.87	2.67	1.07	0.27	0.27